Details of Disease

General Information of Disease (ID: DISBI2BT)

Disease Name Anxiety disorder
Synonyms anxiety; anxiety disorder; anxiety state
Disease Class 6B00-6B0Z: Anxiety disorder
Definition A category of psychiatric disorders which are characterized by anxious feelings or fear often accompanied by physical symptoms associated with anxiety.
Disease Hierarchy
DIS3J5R8: Mental disorder
DISBI2BT: Anxiety disorder
ICD Code
ICD-11
ICD-11: 6B00-6B0Z
Disease Identifiers
MONDO ID
MONDO_0005618
MESH ID
D001008
UMLS CUI
C0003469
MedGen ID
361
SNOMED CT ID
197480006

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 35 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
(+-)-tetrahydropalmatine DMTCPDI Approved Small molecular drug [1]
Adinazolam DMBHO9Y Approved Small molecular drug [2]
Alpidem DMN7Y9K Approved Small molecular drug [1]
Alprazolam DMC7XDN Approved Small molecular drug [3]
Bentazepam DMRVBWU Approved Small molecular drug [1]
Bromazepam DMY9TCW Approved Small molecular drug [4]
Buspirone DMBS632 Approved Small molecular drug [5]
Butalbital DM9J04X Approved Small molecular drug [6]
Chlordiazepoxide DMTN5XI Approved Small molecular drug [7]
Chlormezanone DMTWUXR Approved Small molecular drug [8]
Clobazam - Lundbeck DMW1OQ0 Approved Small molecular drug [9]
Clorazepate DMC3JST Approved Small molecular drug [10]
Clotiazepam DM59AZT Approved Small molecular drug [11]
Delorazepam DM4IJZL Approved Small molecular drug [1]
Dibenzepin DM3WRBQ Approved Small molecular drug [1]
Dixyrazine DMHMY1Y Approved Small molecular drug [1]
Fludiazepam DMD2K4I Approved Small molecular drug [12]
Halazepam DMPFWO6 Approved Small molecular drug [13]
Hydroxyzine DMF8Y74 Approved Small molecular drug [14]
Lorazepam DM84ZXF Approved Small molecular drug [15]
Luvox DMJKROX Approved Small molecular drug [16]
Mebutamate DM0KYI4 Approved Small molecular drug [1]
Meprobamate DMHM93Y Approved Small molecular drug [17]
Methylphenobarbital DMDSWAG Approved Small molecular drug [18]
Nitrous oxide DMTHWBI Approved Small molecular drug [19]
Opipramol DMPUOXF Approved Small molecular drug [1]
Oxazepam DMXNZM4 Approved Small molecular drug [20]
Paroxetine DM5PVQE Approved Small molecular drug [21]
Pinazepam DM2SFCN Approved Small molecular drug [22]
Prazepam DMEWC7N Approved Small molecular drug [23]
Tandospirone DMPHWU6 Approved Small molecular drug [24]
Tiagabine DMKSQG0 Approved Small molecular drug [25]
Venlafaxine DMR6QH0 Approved Small molecular drug [26]
ZOTEPINE DMF3VXA Approved Small molecular drug [27]
Etizolam DM8TNX3 Phase 4 NA [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 35 Drug(s)
This Disease is Treated as An Indication in 42 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Zatosetron maleate DMWDEFC Phase 3 Small molecular drug [28]
Pagoclone DMHWY2G Phase 2/3 Small molecular drug [29]
Pexacerfont DMBJ15R Phase 2/3 Small molecular drug [30]
ABT-436 DMNAU1V Phase 2 NA [31]
ADX10059 DMGVKHQ Phase 2 NA [32]
AVI-4557 DMQGI73 Phase 2 Antisense drug [33]
AVN 101 DMJFLBC Phase 2 NA [34]
AZD-2327 DM8FZOG Phase 2 Small molecular drug [35]
AZD-7268 DMC48SP Phase 2 Small molecular drug [36]
AZD7325 DMXF26Y Phase 2 Small molecular drug [37]
BNC-210 DMEGDWA Phase 2 NA [38]
FR139317 DMEL5SV Phase 2 Small molecular drug [39]
Itriglumide DM5UFRO Phase 2 Small molecular drug [40]
IW-2143 DMGHGN2 Phase 2 NA [38]
JNJ-42165279 DM72GZO Phase 2 NA [41]
Levotofisopam DMPLDAK Phase 2 Small molecular drug [42]
Lu-AA34893 DM2ZUXK Phase 2 NA [43]
LY-156735 DM5IX9M Phase 2 Small molecular drug [44]
NS-2710 DMMUR6V Phase 2 Small molecular drug [45]
ONO-2333Ms DMOT0WR Phase 2 NA [46]
ORG-13011 DMAWXJT Phase 2 Small molecular drug [47]
Orvepitant DMSO846 Phase 2 Small molecular drug [48]
PH-94B DMNB2EO Phase 2 NA [49]
PIKAMILONE DMAFZ84 Phase 2 Small molecular drug [50]
S-15535 DMKTLSD Phase 2 Small molecular drug [51]
S-16924 DML2D30 Phase 2 Small molecular drug [52]
SARIPIDEM DM5R89X Phase 2 Small molecular drug [53]
SRX-246 DMMU41F Phase 2 Small molecular drug [47]
SRX246 DMKOTUJ Phase 2 Small molecular drug [54]
SSR125543 DMGJEB8 Phase 2 Small molecular drug [55]
SSR149415 DMCMD93 Phase 2 Small molecular drug [56]
ST-101 DMVUXLC Phase 2 Small molecular drug [57]
Zalospirone DMJN3BA Phase 2 Small molecular drug [58]
ADX71149 DMBUOX4 Phase 1 NA [59]
AF-05 DMT2KZ7 Phase 1 Small molecular drug [60]
GSK586529 DM5E9LX Phase 1 NA [61]
NMRA-511 DM3V9OJ Phase 1 Small molecule [62]
NSD-788 DM5QHID Phase 1 NA [63]
Pivagabine DMQ8DWR Phase 1 Small molecular drug [64]
SPN-805 DM7QOTC Phase 1 NA [65]
SPN-808 DM88JGA Phase 1 NA [66]
Umespirone DMTLNGV Phase 1 Small molecular drug [67]
------------------------------------------------------------------------------------
⏷ Show the Full List of 42 Drug(s)
This Disease is Treated as An Indication in 90 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Suriclone DMC14HL Discontinued in Preregistration Small molecular drug [68]
Cericlamine DMIP1AS Discontinued in Phase 3 Small molecular drug [69]
Deramciclane DM8DUZT Discontinued in Phase 3 Small molecular drug [70]
Flesinoxan DMOIP7R Discontinued in Phase 3 Small molecular drug [71]
LY-544344 DMSC4K1 Discontinued in Phase 3 Small molecular drug [72]
MDL-11939 DMUR3VP Discontinued in Phase 3 Small molecular drug [73]
Pazinaclone DM1FST8 Discontinued in Phase 3 Small molecular drug [74]
Ritanserin DM0X36Y Discontinued in Phase 3 Small molecular drug [75]
Ro-16-6028 DM8M1X0 Discontinued in Phase 3 Small molecular drug [76]
Saredutant DMSRJY3 Discontinued in Phase 3 Small molecular drug [77]
Y-23684 DM3EZ68 Discontinued in Phase 3 Small molecular drug [78]
ABT-089 DM8DT7U Discontinued in Phase 2 Small molecular drug [79]
ALNESPIRONE DMT5KBF Discontinued in Phase 2 Small molecular drug [80]
AP-521 DMWDCG7 Discontinued in Phase 2 NA [81]
AVN 397 DMFCOZL Discontinued in Phase 2 NA [82]
AZD-5455 DM7VVUT Discontinued in Phase 2 NA [83]
BRL-46470 DMIHSOG Discontinued in Phase 2 Small molecular drug [84]
Brofaromine DMTEQ0G Discontinued in Phase 2 Small molecular drug [85]
E-6006 DMVYG2U Discontinued in Phase 2 NA [86]
ELB-139 DM0B23J Discontinued in Phase 2 Small molecular drug [87]
Emapunil DM0RXCK Discontinued in Phase 2 Small molecular drug [88]
GSK 679769 DMSV6KP Discontinued in Phase 2 NA [89]
GSK163090 DMX7DVH Discontinued in Phase 2 Small molecular drug [90]
GV-150013 DMZD023 Discontinued in Phase 2 Small molecular drug [91]
ICI-170809 DMKUVZO Discontinued in Phase 2 Small molecular drug [92]
L-365260 DMT13ZR Discontinued in Phase 2 Small molecular drug [93]
Lirequinil DM5ENKG Discontinued in Phase 2 Small molecular drug [94]
LY354740 DM08BIZ Discontinued in Phase 2 Small molecular drug [95]
NGD 91-3 DMDAUCR Discontinued in Phase 2 NA [96]
PD-134308 DM80UNM Discontinued in Phase 2 Small molecular drug [97]
RO-48-6791 DMH912O Discontinued in Phase 2 Small molecular drug [98]
Robalzotan DMZAISC Discontinued in Phase 2 Small molecular drug [99]
Romergoline DMYDWHN Discontinued in Phase 2 Small molecular drug [100]
SERAZAPINE HYDROCHLORIDE DM75ZO0 Discontinued in Phase 2 Small molecular drug [101]
SL-65.1498 DMS8AHE Discontinued in Phase 2 NA [102]
AZD-3783 DM3AEV0 Discontinued in Phase 1 NA [103]
AZD6280 DMFAZLU Discontinued in Phase 1 Small molecular drug [104]
BINOSPIRONE MESYLATE DM3HRQI Discontinued in Phase 1 Small molecular drug [105]
CCD-3693 DMMEC1W Discontinued in Phase 1 Small molecular drug [106]
Ebalzotan DMSOH09 Discontinued in Phase 1 Small molecular drug [107]
Eptapirone DMFGTMR Discontinued in Phase 1 Small molecular drug [108]
F-2692 DMHWPBY Discontinued in Phase 1 Small molecular drug [109]
Gedocarnil DMNFWR1 Discontinued in Phase 1 Small molecular drug [110]
Lu-AA37096 DMMYL1B Discontinued in Phase 1 NA [111]
Mirisetron maleate DMC2V5J Discontinued in Phase 1 Small molecular drug [112]
Nerisopam DMK5VB2 Discontinued in Phase 1 Small molecular drug [113]
RO-48-8684 DMOX8AD Discontinued in Phase 1 NA [114]
SB-247853 DMOVLDT Discontinued in Phase 1 NA [115]
SR 144190 DMK4XT8 Discontinued in Phase 1 Small molecular drug [116]
SUN-8399 DMBCQFH Discontinued in Phase 1 Small molecular drug [117]
U-78875 DM2WOPX Discontinued in Phase 1 Small molecular drug [118]
U-93385 DMMSWJ3 Discontinued in Phase 1 Small molecular drug [119]
WAY-100289 DM3GD7V Discontinued in Phase 1 Small molecular drug [120]
WAY-181187 DM8SVHI Discontinued in Phase 1 Small molecular drug [121]
AHR-14042 DMEHLRJ Terminated NA [126]
AZD-1134 DMPCFRN Terminated Small molecular drug [127]
Befiperide DMGAPH1 Terminated NA [128]
CGS-12066B DM6MEX4 Terminated Small molecular drug [129]
CGS-18102A DM4W3MU Terminated Small molecular drug [130]
Co-122739 DM7CSV1 Terminated Small molecular drug [131]
Co-60549 DMGIZHX Terminated NA [132]
DAA-1097 DM3LJK5 Terminated Small molecular drug [133]
DMP-696 DMNSDM1 Terminated Small molecular drug [134]
Du-123015 DMX5SN8 Terminated NA [135]
E-2011 DMD4GQ8 Terminated NA [136]
Endixaprine DMBYXA8 Terminated Small molecular drug [137]
Girisopam DMSVMF2 Terminated Small molecular drug [138]
GR-131663 DMKAGLV Terminated NA [139]
GR-133347 DMNRJA0 Terminated NA [140]
GR-159897 DMLQ71Y Terminated Small molecular drug [141]
GT-2203 DMJ4PNR Terminated NA [142]
HT-90B DMQINWF Terminated NA [143]
ICI-169369 DMQ0IOF Terminated Small molecular drug [144]
Ipsapirone DMEJU1L Terminated Small molecular drug [145]
LU-29252 DMDHLUC Terminated NA [146]
LY-293284 DMH21JG Terminated Small molecular drug [147]
LY288513 DMG8YE9 Terminated Small molecular drug [148]
Miltirone DMZNWAV Terminated Small molecular drug [149]
NBI-37582 DM3JY2N Terminated Small molecular drug [150]
NGD-91-1 DMU10EB Terminated NA [151]
NNC-13-8119 DMMOAN0 Terminated NA [152]
NSD-721 DMF2XMA Terminated NA [153]
Org-34116 DMB0IQT Terminated NA [154]
Org-37684 DMY3LXH Terminated Small molecular drug [155]
Ro-19-8022 DMFRCM2 Terminated Small molecular drug [156]
S-14506 DM05IQU Terminated Small molecular drug [157]
SC-241 DM7I6VO Terminated NA [158]
SDZ-ICM-567 DMN5IY7 Terminated Small molecular drug [159]
U-90042 DMTMZJ4 Terminated Small molecular drug [160]
XR-368 DMX0PTO Terminated NA [161]
------------------------------------------------------------------------------------
⏷ Show the Full List of 90 Drug(s)
This Disease is Treated as An Indication in 4 Preclinical Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
CRA1000 DMWMBIV Preclinical Small molecular drug [122]
RWJ-51204 DMMVS07 Preclinical Small molecular drug [123]
SNAP-7941 DM5KE4R Preclinical Small molecular drug [124]
TP-023 DM6W9YM Preclinical NA [125]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 23 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
ABIO 09-01 DM0LUOM Investigative NA [162]
ADX-88178 DM70H6P Investigative Small molecular drug [163]
AVN-628 DMAP2J3 Investigative NA [164]
Benzodiazepine DM9H34M Investigative Small molecular drug [165]
BHF-177 DMP21ST Investigative Small molecular drug [166]
BMS-561388 DM3WBKN Investigative Small molecular drug [167]
C-21191 DMCAO3V Investigative NA [168]
CGS-19480A DMC41UH Investigative NA [169]
CR-5542 DM0DSWK Investigative NA [164]
CSC-700008 DMZTYNY Investigative NA [164]
CXB-724 DMUXFDK Investigative NA [164]
DBP-192 DMRX20U Investigative NA [164]
GABA-B receptor PAM DMOF7JL Investigative NA [170]
GIDAZEPAM DMASR6T Investigative Small molecular drug [171]
GSK-2210875 DM0DKQN Investigative Small molecular drug [172]
MP-100 DM8N1KZ Investigative NA [164]
Org-231295 DMTFGYH Investigative Small molecular drug [173]
PT-00114 DMI7WXB Investigative NA [164]
RPR-107836 DM9ODEZ Investigative NA [174]
SCH-221510 DMHOUSR Investigative Small molecular drug [175]
TGSC01AA(4) DM1BVW3 Investigative NA [165]
U-89854 DMI6VAX Investigative NA [165]
VII-7-B DMYS5TK Investigative NA [164]
------------------------------------------------------------------------------------
⏷ Show the Full List of 23 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 183 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ABAT TTT2LD9 Limited Genetic Variation [176]
ADCYAP1 TTW4LYC Limited Biomarker [177]
ADRA2B TTWM4TY Limited Altered Expression [178]
APLN TT87D3J Limited Altered Expression [179]
ARSA TTYQANR Limited Biomarker [180]
CACNA1C TTZIFHC Limited Genetic Variation [181]
CAMKK2 TTV298Y Limited Biomarker [182]
CCKBR TTVFO0U Limited Altered Expression [183]
CCL3 TT8I4WB Limited Biomarker [184]
CFI TT6ATLX Limited Biomarker [185]
CFP TTLA0VS Limited Genetic Variation [186]
CHRNA2 TTF4E0J Limited Biomarker [187]
CHRNA7 TTLA931 Limited Genetic Variation [188]
CNP TT71P0H Limited Altered Expression [189]
CPM TTVOH2M Limited Biomarker [190]
CRHBP TT3PKZE Limited Biomarker [191]
CRY1 TT5MLZR Limited Genetic Variation [192]
CRY2 TTAO58M Limited Biomarker [192]
DAO TT7Y3EJ Limited Biomarker [193]
DBH TTYIP79 Limited Genetic Variation [194]
DYRK1A TTSBVFO Limited Biomarker [195]
ELK3 TT5OJMV Limited Genetic Variation [196]
FDPS TTIKWV4 Limited Biomarker [197]
FES TTLBY21 Limited Biomarker [197]
FKBP4 TTHY0FT Limited Genetic Variation [198]
FST TTDNM9W Limited Biomarker [199]
GAL TTXZAJ5 Limited Biomarker [200]
GALR2 TTBPW3J Limited Biomarker [201]
GPER1 TTDSB34 Limited Biomarker [202]
GPNMB TT7315J Limited Genetic Variation [203]
GPR55 TTNET8J Limited Biomarker [204]
GRIA2 TTWM461 Limited Altered Expression [205]
HCRTR1 TT60Q8D Limited Genetic Variation [206]
HSD11B2 TT9H85R Limited Genetic Variation [207]
HTR2A TTJQOD7 Limited Genetic Variation [208]
HTR6 TTJS8PY Limited Biomarker [209]
HTT TTIWZ0O Limited Biomarker [210]
IL15RA TTGN89I Limited Altered Expression [211]
JAG2 TTOJY1B Limited Genetic Variation [212]
MAOB TTGP7BY Limited Biomarker [213]
MC1R TT0MV2T Limited Altered Expression [214]
MC4R TTD0CIQ Limited Biomarker [215]
MCHR1 TTX4RTB Limited Biomarker [216]
MECP2 TTTAU9R Limited Biomarker [217]
MGLL TTZ963I Limited Biomarker [218]
MKNK1 TTEZAUX Limited Genetic Variation [219]
MSMB TTYH1ZK Limited Biomarker [220]
NFKB2 TTKLNRV Limited Biomarker [221]
NPTX2 TTNJ5A6 Limited Biomarker [222]
NPY2R TTJ6WK9 Limited Biomarker [223]
NPY5R TTY6EWA Limited Genetic Variation [224]
NQO2 TTJLP0R Limited Genetic Variation [225]
NR1D1 TTAD1O8 Limited Biomarker [226]
NTRK3 TTXABCW Limited Biomarker [227]
OPRK1 TTQW87Y Limited Biomarker [228]
P2RX4 TT1NLOA Limited Biomarker [229]
PDE10A TTJW4LU Limited Biomarker [230]
PDE7B TTWIEY9 Limited Biomarker [231]
PLTP TTZF6SN Limited Biomarker [232]
PMEL TT8MK59 Limited Biomarker [221]
PREP TTNGKET Limited Biomarker [233]
PSMB6 TT8EPLT Limited Altered Expression [234]
PYY TTVFJLX Limited Biomarker [235]
SDHD TTVH9W8 Limited Biomarker [236]
SF3B1 TTL2WUI Limited Biomarker [237]
SGCA TTS9Q5V Limited Genetic Variation [238]
SIGMAR1 TT5TPI6 Limited Biomarker [239]
SLC18A2 TTNZRI3 Limited Genetic Variation [240]
SLC1A1 TTG2A6F Limited Altered Expression [241]
SLC1A3 TT8WRDA Limited Altered Expression [205]
SLC2A9 TTIF3GB Limited Genetic Variation [242]
SLC33A1 TTL69WB Limited Biomarker [243]
SLC38A1 TT1YE9Z Limited Genetic Variation [244]
SLC6A1 TTPRKM0 Limited Biomarker [245]
SLC6A2 TTAWNKZ Limited Biomarker [246]
SRD5A1 TTTU72V Limited Genetic Variation [247]
TAAR1 TTIU98M Limited Biomarker [248]
TH TTUHP71 Limited Altered Expression [249]
TRPC5 TT32NQ1 Limited Biomarker [250]
TSPO TTPTXIN Limited Biomarker [251]
UNC13B TT948FC Limited Biomarker [252]
WAS TTE8T73 Limited Altered Expression [253]
GABRA5 TTNZPQ1 Disputed Genetic Variation [254]
GRIK1 TT0MYE2 Disputed Biomarker [255]
LIPA TTS8T1M Disputed Genetic Variation [256]
MBOAT4 TTSYOWR Disputed Biomarker [257]
ADRA2A TTWG9A4 moderate Biomarker [258]
ALDH2 TTFLN4T moderate Genetic Variation [259]
BCHE TT3MSAO moderate Genetic Variation [260]
DNMT3B TT6VZ78 moderate Biomarker [261]
ESR2 TTOM3J0 moderate Biomarker [262]
HTR2C TTWJBZ5 moderate Biomarker [263]
L1CAM TTC9D3K moderate Biomarker [264]
ADCY2 TTBQ9IM Strong Genetic Variation [265]
ADCYAP1R1 TT5OREU Strong Genetic Variation [266]
ADRA1A TTNGILX Strong Biomarker [267]
ALPL TTMR5UV Strong Genetic Variation [268]
AMD1 TTBFROQ Strong Biomarker [269]
AOAH TT2EJXQ Strong Biomarker [270]
AVPR1A TT4TFGN Strong Biomarker [271]
AVPR1B TTL9MHW Strong Therapeutic [272]
BPI TTXCSDR Strong Biomarker [273]
BRS3 TTKYEPM Strong Biomarker [267]
CCKAR TTCG0AL Strong Biomarker [274]
CD160 TTOFEAS Strong Biomarker [275]
CDCA8 TT04YCM Strong Genetic Variation [276]
CHRNA4 TT4H1MQ Strong Biomarker [277]
CHRNA5 TTH2QRX Strong Biomarker [278]
CHRNB2 TT5KPZR Strong Biomarker [279]
CNGB3 TT0LJCG Strong Genetic Variation [265]
CNR2 TTMSFAW Strong Biomarker [280]
CNTF TTGEM5Q Strong Biomarker [281]
CRHR2 TTIY658 Strong Biomarker [282]
CXCR6 TT2BVUA Strong Biomarker [267]
CYP2C19 TTZ58XG Strong Genetic Variation [283]
CYP2D6 TTVG215 Strong Genetic Variation [284]
DNMT1 TT6S2FE Strong Biomarker [285]
EPHA5 TTV9KOD Strong Genetic Variation [286]
FOS TTOM5AU Strong Biomarker [287]
GHSR TTWDC17 Strong Biomarker [288]
GRIA1 TTVPQTF Strong Biomarker [289]
HCN1 TTNB6UQ Strong Biomarker [290]
HCN4 TTQP04A Strong Biomarker [291]
HCRT TTU5HJP Strong Biomarker [292]
HDAC2 TTSHTOI Strong Altered Expression [293]
HTR1B TTK8CXU Strong Altered Expression [294]
HTR3A TTPC4TU Strong Biomarker [295]
IDO1 TTZJYKH Strong Biomarker [296]
IFNA2 TTSIUJ9 Strong Biomarker [297]
LPAR2 TTB7Y8I Strong Biomarker [267]
MAP2K5 TTV3O87 Strong Genetic Variation [298]
MAPT TTS87KH Strong Biomarker [299]
MDK TTV8UE7 Strong Biomarker [300]
MVD TTE5J6X Strong Genetic Variation [301]
NPEPPS TT371QC Strong Biomarker [302]
NPSR1 TTV1C0Z Strong Genetic Variation [303]
NPY1R TTRK9JT Strong Biomarker [304]
NR3C1 TTOZRK6 Strong Biomarker [305]
NR3C2 TT26PHO Strong Biomarker [306]
NTF3 TTZHKV9 Strong Biomarker [307]
OAT TTTSCQ2 Strong Biomarker [308]
OPRM1 TTKWM86 Strong Genetic Variation [309]
OXTR TTSCIUP Strong Genetic Variation [310]
P2RX7 TT473XN Strong Biomarker [311]
PAM TTF4ZPC Strong Biomarker [312]
PDE4B TTVIAT9 Strong Altered Expression [313]
PHF8 TT81PFE Strong Biomarker [314]
PTPRZ1 TT4SEA8 Strong Biomarker [315]
RAD51 TTC0G1L Strong Genetic Variation [265]
RAPGEF3 TTOE7I0 Strong Altered Expression [316]
RAPGEF4 TTOS63B Strong Biomarker [316]
RGS2 TTKB7T3 Strong Biomarker [317]
RXFP3 TT64ZVP Strong Biomarker [318]
SLC6A3 TTVBI8W Strong Altered Expression [249]
SLCO1B1 TTFGXEB Strong Genetic Variation [286]
SNCA TT08OSU Strong Genetic Variation [319]
SSTR4 TTAE1BR Strong Biomarker [267]
TACR1 TTZPO1L Strong Biomarker [320]
TACR3 TTBPGLU Strong Altered Expression [321]
TDO2 TTXNCBV Strong Biomarker [296]
TPH1 TTZSJHV Strong Biomarker [322]
TSSK2 TTA3Z2W Strong Biomarker [323]
AGRP TT4DE1O Definitive Altered Expression [324]
C9orf72 TTA4SHR Definitive Biomarker [325]
CASP2 TT12VNG Definitive Altered Expression [326]
CNR1 TT6OEDT Definitive Altered Expression [327]
CRH TTA7YIZ Definitive Biomarker [328]
CRHR1 TT7EFHR Definitive Biomarker [329]
CRP TTWRN6M Definitive Biomarker [330]
DPYSL2 TTZCW3T Definitive Altered Expression [331]
DRD2 TTEX248 Definitive Biomarker [332]
GABRA2 TTBMV1G Definitive Biomarker [333]
GABRQ TTXDUR9 Definitive Biomarker [334]
GALNS TTT9YPO Definitive Genetic Variation [335]
GNRHR TT8R70G Definitive Biomarker [336]
GRM5 TTHS256 Definitive Biomarker [337]
GUCY2C TTLDPRG Definitive Altered Expression [338]
MIF TT6804T Definitive Genetic Variation [339]
PDE2A TTJGW1Z Definitive Biomarker [340]
SERPINA1 TTA7UJC Definitive Biomarker [341]
SLC22A2 TT0XOJN Definitive Genetic Variation [342]
TNF TTF8CQI Definitive Biomarker [330]
TRPM2 TTEBMN7 Definitive Biomarker [343]
------------------------------------------------------------------------------------
⏷ Show the Full List of 183 DTT(s)
This Disease Is Related to 4 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC17A8 DTAGDH7 Limited Altered Expression [344]
SLC26A1 DTJ785O Limited Genetic Variation [244]
SLC32A1 DTXQYLR Limited Biomarker [345]
SLC17A7 DTNK0FR Definitive Biomarker [346]
------------------------------------------------------------------------------------
This Disease Is Related to 11 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
AKR1C1 DE7P2FB Limited Altered Expression [247]
CES2 DETHCPD Limited Genetic Variation [347]
PMM2 DEBRX3L Limited Biomarker [348]
PRODH DEVJIHS Limited Genetic Variation [349]
UGT2B15 DENZ6B1 Limited Biomarker [350]
SAT1 DEMWO83 moderate Altered Expression [351]
ADH1B DEEN9RD Strong Genetic Variation [352]
FAAH DEUM1EX Strong Biomarker [353]
PSAT1 DEBS17P Strong Biomarker [302]
THOP1 DE95LJC Strong Biomarker [354]
PER1 DE9HF0I Definitive Altered Expression [355]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 DME(s)
This Disease Is Related to 245 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ACACA OT5CQPZY Limited Biomarker [356]
ACAD8 OT3JI5GB Limited Biomarker [357]
ALDH1L1 OT15HOJX Limited Biomarker [358]
ALLC OTZE4XV7 Limited Biomarker [359]
ALYREF OTOF2ADD Limited Biomarker [360]
ANKK1 OT0OM1O0 Limited Biomarker [361]
APOBEC3C OTPL0AI1 Limited Genetic Variation [362]
ARC OTN2QQPG Limited Biomarker [363]
ARHGEF9 OTB1FLIW Limited Genetic Variation [364]
ASCC2 OT3B204T Limited Biomarker [221]
ASXL1 OTX931AW Limited Biomarker [237]
BAIAP3 OTS1H0J0 Limited Genetic Variation [252]
BMS1 OTEGQ8ZO Limited Biomarker [356]
BTG3 OT9ANHVT Limited Biomarker [365]
CBLN2 OT29SSBE Limited Biomarker [366]
CBLN4 OTO7QW6Y Limited Genetic Variation [366]
CENPV OTPQ0KT9 Limited Altered Expression [367]
CITED2 OT812TV7 Limited Biomarker [180]
COPE OTBKHBT7 Limited Genetic Variation [368]
CORT OTX3GUHB Limited Biomarker [369]
CPD OT2CS64Y Limited Biomarker [370]
CPEB1 OTLCXC6H Limited Biomarker [371]
CPED1 OTJJPZOZ Limited Genetic Variation [372]
CREM OTJIJ5AL Limited Biomarker [373]
CTNNBL1 OT6KLHPA Limited Biomarker [374]
DCLRE1C OTW3KB1I Limited Genetic Variation [375]
DCX OTISR7K3 Limited Biomarker [376]
DGCR6 OTBOXM33 Limited Altered Expression [377]
DISC1 OT43AW4H Limited Biomarker [378]
DLGAP3 OT0GR2F6 Limited Biomarker [379]
DLK2 OT56Y83S Limited Genetic Variation [380]
DUSP2 OTH54FMR Limited Biomarker [381]
EAF2 OTSOET5L Limited Biomarker [382]
EEF1A2 OT9Z23K5 Limited Biomarker [383]
ENDOU OTB7OF7Y Limited Biomarker [384]
EPRS1 OTXK0FLB Limited Biomarker [385]
EXOSC6 OTAC10N6 Limited Biomarker [384]
FBXO7 OTGTN8TJ Limited Genetic Variation [386]
FGFBP3 OTWM1KCM Limited Biomarker [387]
FOXG1 OTAW57J4 Limited Biomarker [388]
GPHN OTAKK1SV Limited Biomarker [364]
GPR26 OTBDYUOH Limited Biomarker [389]
HNRNPU OTLQN1E2 Limited Biomarker [390]
HOMER1 OTWFD3SI Limited Biomarker [391]
IFT122 OTSK3OAD Limited Biomarker [392]
IGSF9B OTNOMYYQ Limited Biomarker [393]
IKBKE OT5VYOSM Limited Biomarker [394]
KCNS1 OTD8GEO0 Limited Biomarker [395]
KPNA1 OTEMVAJ6 Limited Biomarker [396]
LAMA1 OTQZMP86 Limited Genetic Variation [397]
LAT2 OTWJDKIH Limited Biomarker [398]
LXN OTZQ2M6Y Limited Biomarker [399]
MAGED1 OT6EOLFC Limited Biomarker [400]
MPI OTBH6ZK1 Limited Biomarker [348]
MT3 OTVCZ7HI Limited Biomarker [401]
NCS1 OT6JHAWM Limited Biomarker [402]
ND2 OTG9OHOX Limited Biomarker [403]
ND6 OTG47B7B Limited Biomarker [403]
NIPBL OTF6OOLU Limited Genetic Variation [404]
NLGN3 OTKDEC1Q Limited Biomarker [405]
NPAS2 OTMRT2TS Limited Biomarker [406]
NPAS4 OTA3HH6W Limited Biomarker [407]
NPC1 OTRIPICX Limited Biomarker [408]
NPFF OT3WXFPR Limited Biomarker [409]
NRG3 OTIFZ5CT Limited Altered Expression [410]
OAS3 OT6E5FYS Limited Biomarker [221]
OCA2 OTDWIGBF Limited Altered Expression [411]
PADI1 OT13WAQX Limited Genetic Variation [412]
PAFAH1B1 OT9T2TCJ Limited Biomarker [237]
PCSK1N OT7ZRW2F Limited Altered Expression [413]
PDIA2 OTC2WMXS Limited Genetic Variation [412]
PHB2 OTCAX3AW Limited Biomarker [414]
PNN OT0HXICH Limited Genetic Variation [415]
PPP1R9B OTDCTHTT Limited Biomarker [416]
PRND OTH4EEMI Limited Genetic Variation [417]
PROS1 OTXQWNOI Limited Biomarker [418]
PSMG1 OTZ5I6UM Limited Biomarker [381]
PTMA OT2W4T1M Limited Genetic Variation [419]
QKI OTTAUGLB Limited Biomarker [230]
RAPH1 OTMQXW7S Limited Biomarker [420]
RASD1 OT2BAJHK Limited Biomarker [421]
RBM8A OT5SR6G0 Limited Biomarker [422]
RCAN1 OT1MVXC7 Limited Biomarker [423]
REM1 OTUXL0HC Limited Genetic Variation [424]
RIT1 OTVNOGOH Limited Genetic Variation [425]
S100A10 OTI71243 Limited Biomarker [384]
SART3 OTC1AM7S Limited Biomarker [221]
SERPINB2 OT72QLZB Limited Biomarker [426]
SGCE OT9F17JB Limited Genetic Variation [427]
SIL1 OTDI85I5 Limited Biomarker [414]
SMR3A OT6NAJJI Limited Genetic Variation [362]
SND1 OTT734JN Limited Biomarker [221]
SPX OTY3G4AR Limited Altered Expression [428]
SRPX OT5B9LXS Limited Genetic Variation [415]
SYN3 OTSGYNA5 Limited Genetic Variation [212]
TAOK2 OTNUMOZ1 Limited Biomarker [429]
TCN1 OTW6A49Y Limited Biomarker [399]
TCOF1 OT4BOYTM Limited Biomarker [430]
TENM1 OTSKSU4V Limited Altered Expression [431]
TIA1 OTGPN3P8 Limited Biomarker [432]
TMEM11 OTL9HDEY Limited Biomarker [348]
TPSG1 OTDESHKT Limited Genetic Variation [433]
TTC1 OTB5X6EG Limited Biomarker [192]
ASB1 OT0NZGEI Disputed Genetic Variation [434]
BPIFA2 OTLFSDZD Disputed Biomarker [435]
GOLPH3 OTDLGYM3 Disputed Biomarker [436]
HOMER2 OT4JGKJF Disputed Biomarker [437]
KCNIP3 OTCQPEM4 Disputed Genetic Variation [438]
LYPD6 OTT45DF7 Disputed Biomarker [439]
PSPH OTV1PVAX Disputed Biomarker [435]
PSPN OT54LLZJ Disputed Biomarker [435]
RIDA OTW4098I Disputed Biomarker [435]
STXBP3 OTTTYMAQ Disputed Biomarker [435]
TTLL5 OTUKOVEM Disputed Biomarker [440]
CAPS2 OT45M743 moderate Biomarker [307]
DTNBP1 OT9UQT2S moderate Biomarker [441]
HMGN1 OTSMGH99 moderate Altered Expression [442]
HOXB8 OTKHOD17 moderate Biomarker [443]
KDM3B OTZU5J5S moderate Biomarker [444]
MOCOS OT0TL3Q5 moderate Genetic Variation [445]
MYT1 OTC3660I moderate Altered Expression [446]
NCOR1 OT04XNOU moderate Biomarker [447]
NEUROD2 OTJMMX9K moderate Altered Expression [448]
PAEP OTQA0NV4 moderate Biomarker [449]
PBX1 OTORABGO moderate Altered Expression [443]
SMCP OTXKY794 moderate Genetic Variation [445]
TMEM132D OTV6I4Z0 moderate Biomarker [450]
ADAMTS2 OTTK22NO Strong Biomarker [451]
ANK3 OTJ3IRBP Strong Biomarker [452]
ARSI OTIANNWW Strong Genetic Variation [453]
ATF7IP OTU6ZA7F Strong Genetic Variation [454]
BAG3 OTVXYUDQ Strong Biomarker [455]
BATF2 OT4XBZC9 Strong Biomarker [456]
C1QL1 OTNQ0G3E Strong Biomarker [282]
CACYBP OTJMZD2T Strong Biomarker [457]
CALM2 OTNYA92F Strong Biomarker [458]
CAMK2G OTHD9KJG Strong Biomarker [459]
CASP8AP2 OTTWT68S Strong Biomarker [460]
CC2D1A OTVPU04K Strong Altered Expression [461]
CCS OTXHT3QO Strong Genetic Variation [462]
CENPJ OTZCQZN5 Strong Biomarker [463]
CIAO3 OT0V91PK Strong Biomarker [464]
CLOCK OTNEOJY7 Strong Biomarker [465]
CNTN3 OTC1274J Strong Altered Expression [466]
CPLX1 OT7UIGTP Strong Biomarker [467]
CREB3L1 OT2JHIHM Strong Biomarker [468]
CSTA OT1K68KE Strong Biomarker [469]
CTRL OTB6NA5O Strong Biomarker [470]
DBI OT884QY9 Strong Genetic Variation [471]
DIXDC1 OT87DXEG Strong Biomarker [472]
DLX4 OTLWVCN4 Strong Genetic Variation [473]
DMTN OTDTKPBW Strong Genetic Variation [474]
DNASE1L3 OTEUIMC2 Strong Biomarker [475]
EBPL OT59J1GY Strong Genetic Variation [196]
EDIL3 OTDVVNS0 Strong Genetic Variation [265]
EOMES OTB9VQFA Strong Biomarker [476]
EYA1 OTHU807A Strong Genetic Variation [276]
FASTK OTTHFZMP Strong Genetic Variation [477]
FGD1 OTV3T64P Strong Biomarker [478]
FLVCR1 OT9XCFOC Strong Biomarker [479]
FMR1 OTWEV0T5 Strong Genetic Variation [480]
FXR1 OTEMQ1SR Strong Biomarker [481]
GALR3 OTXU6PKO Strong Genetic Variation [482]
GIGYF2 OTFNVEJ4 Strong Genetic Variation [265]
GNB1 OTLL7L74 Strong Biomarker [483]
GNLY OTZJKA8C Strong Genetic Variation [484]
GPR42 OTEB0ROY Strong Biomarker [267]
GTF2I OTUYL1TQ Strong Genetic Variation [485]
GYPA OTABU4YV Strong Biomarker [486]
INO80C OTKXHGET Strong Biomarker [487]
INPP5K OTQFLQKA Strong Biomarker [469]
INSRR OT3F75WA Strong Genetic Variation [488]
KANK2 OT3SZIWM Strong Biomarker [457]
LPP OT6TU8SE Strong Biomarker [489]
LSAMP OTYXVQX2 Strong Biomarker [490]
LTBP3 OTME98V7 Strong Genetic Variation [491]
MAGI2 OTXDDKZS Strong Biomarker [492]
MANEA OTV7L8I6 Strong Genetic Variation [493]
MAP6 OTPUI00F Strong Biomarker [494]
MBD5 OTFHT4MO Strong Genetic Variation [495]
MCIDAS OTK1JVAH Strong Biomarker [496]
MFAP3L OTNMHSAH Strong Genetic Variation [497]
MZB1 OT071TET Strong Biomarker [177]
NBEAL2 OTMCAXWR Strong Biomarker [498]
NDE1 OT2N8Q17 Strong Biomarker [499]
NLGN2 OTHDYL3H Strong Altered Expression [500]
NLGN4Y OT7E1S57 Strong Altered Expression [501]
NPTN OTAQKSAU Strong Biomarker [502]
OR2AG1 OTEITRP4 Strong Genetic Variation [503]
OR8A1 OT4NEBBX Strong Genetic Variation [497]
OSR1 OTB19LEQ Strong Genetic Variation [504]
OTP OTS0JN6Y Strong Biomarker [505]
OXT OT48M72Z Strong Therapeutic [506]
PANX1 OTXPEDOK Strong Altered Expression [507]
PDSS1 OTXGVHAB Strong Biomarker [508]
PEG3 OTHQW98S Strong Biomarker [509]
PELI1 OTMLBCLC Strong Genetic Variation [510]
PER3 OTVKYVJA Strong Genetic Variation [511]
PICALM OTQVRPMQ Strong Biomarker [458]
PLAG1 OTT9AJQY Strong Biomarker [302]
PPM1F OTU0MVR7 Strong Altered Expression [459]
PRDM6 OTKY12D9 Strong Genetic Variation [510]
PTPRT OTV5TXNN Strong Genetic Variation [265]
PVALB OTZW1WVQ Strong Biomarker [512]
RAI1 OTKLQU00 Strong Biomarker [513]
RBM14 OTO9GMBD Strong Biomarker [457]
REST OTLL92LQ Strong Altered Expression [514]
RGS1 OTGXJYMG Strong Genetic Variation [515]
RPS4Y1 OTIFRF9S Strong Genetic Variation [501]
SDK1 OTX26906 Strong Genetic Variation [265]
SEPHS1 OTZ19I59 Strong Biomarker [508]
SLITRK5 OTTSUSB8 Strong Biomarker [516]
SMIM20 OTZI1KFR Strong Biomarker [517]
SMS OT8JYKNH Strong Biomarker [518]
SNAP91 OTE3EXWZ Strong Biomarker [458]
SOSTDC1 OTAKDNSM Strong Biomarker [519]
SOX13 OTCIF6KC Strong Genetic Variation [520]
STX2 OTO2IDDR Strong Biomarker [508]
SYNGR1 OT0MBUK5 Strong Biomarker [313]
TAFA2 OTU6WP6J Strong Biomarker [521]
TBX4 OTW58FG4 Strong Biomarker [508]
TG OT3ELHIJ Strong Biomarker [522]
TP53INP1 OT2363Z9 Strong Biomarker [457]
TSACC OT3QW6PH Strong Biomarker [457]
TSKU OT1XMRIM Strong Genetic Variation [523]
TSSK1B OTRATM7R Strong Biomarker [323]
ADA2 OTGCV24S Definitive Genetic Variation [524]
AQP6 OTXS6UYY Definitive Biomarker [525]
BLOC1S4 OTDCFUJC Definitive Biomarker [526]
CASKIN1 OTQ9I0QU Definitive Biomarker [527]
CPSF4 OT53UK5L Definitive Genetic Variation [528]
CPZ OT5HUR28 Definitive Altered Expression [529]
CRYGD OTW29JC4 Definitive Biomarker [530]
DUSP26 OTI7WIYN Definitive Biomarker [531]
KIF22 OTY6X6BL Definitive Biomarker [525]
KTN1 OTQAV541 Definitive Biomarker [532]
NANOS1 OT3UNZZY Definitive Genetic Variation [533]
NPS OTEG25A2 Definitive Biomarker [534]
NR2F1 OTGWZWYL Definitive Biomarker [535]
P4HTM OTKELL7F Definitive Altered Expression [536]
PAGR1 OTXR5PQ8 Definitive Genetic Variation [335]
SHANK1 OTK8PV0S Definitive Biomarker [537]
TAC1 OTM842YW Definitive Biomarker [538]
TMEM59 OTX4EKES Definitive Biomarker [539]
TMPRSS13 OTMAOAP3 Definitive Biomarker [220]
------------------------------------------------------------------------------------
⏷ Show the Full List of 245 DOT(s)

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Drug information of Adinazolam, 2008. eduDrugs.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7111).
4 Drug information of Bromazepam, 2008. eduDrugs.
5 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 36).
6 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7138).
7 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3370).
8 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7323).
9 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7149).
10 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7548).
11 Drug information of Clotiazepam, 2008. eduDrugs.
12 Drug information of Fludiazepam, 2008. eduDrugs.
13 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7195).
14 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7199).
15 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5884).
16 ClinicalTrials.gov (NCT00743834) Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD). U.S. National Institutes of Health.
17 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7225).
18 Drug information of Methylphenobarbital, 2008. eduDrugs.
19 Anaesthetic drugs: linking molecular actions to clinical effects. Curr Pharm Des. 2006;12(28):3665-79.
20 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7253).
21 Paroxetine FDA Label
22 Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes. 1992 Apr;41(4):476-83.
23 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7275).
24 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 55).
25 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4818).
26 Venlafaxine FDA Label
27 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 103).
28 Concise Dictionary of Pharmacological Agents: Properties and Synonyms, Dr. Ian Morton,I.K. Morton,Judith M. Hall. Page(298).
29 ClinicalTrials.gov (NCT00830154) A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering. U.S. National Institutes of Health.
30 ClinicalTrials.gov (NCT00481325) Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder. U.S. National Institutes of Health.
31 ClinicalTrials.gov (NCT01741142) Efficacy and Safety Study of ABT-436 in Major Depressive Disorder. U.S. National Institutes of Health.
32 ClinicalTrials.gov (NCT00820105) ADX10059 Migraine Prevention Study. U.S. National Institutes of Health.
33 Phosphorodiamidate morpholino antisense oligomers inhibit expression of human cytochrome P450 3A4 and alter selected drug metabolism. Drug Metab Dispos. 2002 Jul;30(7):757-62.
34 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030006)
35 ClinicalTrials.gov (NCT00759395) Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD). U.S. National Institutes of Health.
36 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7824).
37 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7712).
38 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030421)
39 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027682)
40 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 909).
41 ClinicalTrials.gov (NCT02498392) An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress.
42 ClinicalTrials.gov (NCT01519687) Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout. U.S. National Institutes of Health.
43 ClinicalTrials.gov (NCT00622245) Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression. U.S. National Institutes of Health.
44 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1351).
45 GABAA receptor subtype-selective modulators. I. alpha2/alpha3-selective agonists as non-sedating anxiolytics. Curr Top Med Chem. 2011;11(9):1176-202.
46 ClinicalTrials.gov (NCT00514865) Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder. U.S. National Institutes of Health.
47 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
48 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020168)
49 ClinicalTrials.gov (NCT01217788) Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia. U.S. National Institutes of Health.
50 ClinicalTrials.gov (NCT00940186) Clinical Pharmacokinetics Study on Pikamilone. U.S. National Institutes of Health.
51 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 26).
52 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 167).
53 Behavioural effects of novel benzodiazepine (omega) receptor agonists and partial agonists: increases in punished responding and antagonism of the pentylenetetrazole cue. Behav Pharmacol. 1995 Mar;6(2):116-126.
54 ClinicalTrials.gov (NCT02922166) Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans. U.S. National Institutes of Health.
55 ClinicalTrials.gov (NCT01034995) A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder. U.S. National Institutes of Health.
56 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2202).
57 ClinicalTrials.gov (NCT00842673) Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease. U.S. National Institutes of Health.
58 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 58).
59 ClinicalTrials.gov (NCT01323205) Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia. U.S. National Institutes of Health.
60 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031488)
61 ClinicalTrials.gov (NCT00703547) A First Time in Human Study of GSK586529 in Healthy Volunteers. U.S. National Institutes of Health.
62 Clinical pipeline report, company report or official report of Neumora Therapeutics
63 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028006)
64 ClinicalTrials.gov (NCT00814931) Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males. U.S. National Institutes of Health.
65 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029715)
66 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029716)
67 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000698)
68 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000574)
69 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001340)
70 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5490).
71 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1).
72 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018821)
73 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 186).
74 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000717)
75 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 97).
76 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4146).
77 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2111).
78 The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist.. Br J Pharmacol. 1994 April; 111(4): 1170-1178.
79 Emerging drugs for attention-deficit/hyperactivity disorder. Expert Opin Emerg Drugs. 2007 Sep;12(3):423-34.
80 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001421)
81 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004776)
82 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031584)
83 AZD 5455 AstraZeneca discontinued, Europe (anxiety), R & D Focus Drug News, July 18, 2005
84 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2302).
85 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000689)
86 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015484)
87 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020261)
88 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8704).
89 Emerging drugs for chemotherapy-induced emesis. Expert Opin Emerg Drugs. 2006 Mar;11(1):137-51.
90 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026154)
91 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3503).
92 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001766)
93 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 879).
94 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001968)
95 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1393).
96 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011480)
97 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000702)
98 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007556)
99 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 72).
100 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001388)
101 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001373)
102 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014726)
103 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025787)
104 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027607)
105 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000677)
106 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006723)
107 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006909)
108 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010848)
109 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001416)
110 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005436)
111 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027649)
112 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003649)
113 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001415)
114 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007572)
115 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016366)
116 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008589)
117 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001433)
118 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001194)
119 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002172)
120 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001552)
121 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3240).
122 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3498).
123 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015754)
124 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1313).
125 Use of multicomponent reactions in developing small-molecule tools to study GABAA receptor mechanism and function. Future Med Chem. 2011 February; 3(2): 243-250.
126 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006305)
127 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017898)
128 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000673)
129 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 109).
130 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001927)
131 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012983)
132 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007012)
133 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012540)
134 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3499).
135 Neither in vivo MRI nor behavioural assessment indicate therapeutic efficacy for a novel 5HT1A agonist in rat models of ischaemic stroke. BMC Neuroscience 2009, 10:82.
136 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002928)
137 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000722)
138 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005437)
139 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003455)
140 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003420)
141 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2115).
142 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008938)
143 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003558)
144 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 273).
145 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 42).
146 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003571)
147 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 19).
148 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 902).
149 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003466)
150 Strategies for producing faster acting antidepressants. Drug Discov Today. 2005 Apr 15;10(8):578-85.
151 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001122)
152 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004060)
153 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010233)
154 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011369)
155 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 171).
156 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001584)
157 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 24).
158 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008644)
159 Determination of SDZ ICM 567 in blood and muscle microdialysis samples by microbore liquid chromatography with ultraviolet and fluorescence detection. J Chromatogr B Biomed Sci Appl. 1997 Oct 24;700(1-2):191-200.
160 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001470)
161 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004007)
162 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1558).
163 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6238).
164 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
165 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2879).
166 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7848).
167 8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists. J Med Chem. 2009 May 14;52(9):3073-83.
168 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 415).
169 WO patent application no. 2012,0025,83, Method for treating schizophrenia and related diseases with a combination therapy.
170 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 241).
171 Discriminative effects of phenazepam and gidazepam in rats: comparison with other GABA-related drugs. Pharmacol Biochem Behav. 1999 Oct;64(2):397-401.
172 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6435).
173 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4339).
174 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 77).
175 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 320).
176 TP003 is a non-selective benzodiazepine site agonist that induces anxiolysis via 2GABA(A) receptors.Neuropharmacology. 2018 Dec;143:71-78. doi: 10.1016/j.neuropharm.2018.09.026. Epub 2018 Sep 18.
177 PACAP neurons in the ventral premammillary nucleus regulate reproductive function in the female mouse.Elife. 2018 Jun 15;7:e35960. doi: 10.7554/eLife.35960.
178 Alpha2B-Adrenergic Receptor Overexpression in the Brain Potentiate Air Pollution-induced Behavior and Blood Pressure Changes.Toxicol Sci. 2019 May 1;169(1):95-107. doi: 10.1093/toxsci/kfz025.
179 Apelin-13 enhances contextual fear extinction in rats.Neurosci Lett. 2019 Nov 1;712:134487. doi: 10.1016/j.neulet.2019.134487. Epub 2019 Sep 9.
180 Anxiety Disorders Interview Schedule-Autism Addendum: Reliability and Validity in Children With Autism Spectrum Disorder.J Clin Child Adolesc Psychol. 2017 Jan-Feb;46(1):88-100. doi: 10.1080/15374416.2016.1233501. Epub 2016 Dec 7.
181 Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood.Mol Psychiatry. 2018 Mar;23(3):533-543. doi: 10.1038/mp.2017.133. Epub 2017 Jul 11.
182 Autophosphorylation of CaMKK2 generates autonomous activity that is disrupted by a T85S mutation linked to anxiety and bipolar disorder.Sci Rep. 2015 Sep 23;5:14436. doi: 10.1038/srep14436.
183 Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109761. doi: 10.1016/j.pnpbp.2019.109761. Epub 2019 Sep 14.
184 Daytime melatonin levels in saliva are associated with inflammatory markers and anxiety disorders.Psychoneuroendocrinology. 2020 Feb;112:104514. doi: 10.1016/j.psyneuen.2019.104514. Epub 2019 Nov 14.
185 The Edinburgh Postpartum Depression Scale: Stable structure but subscale of limited value to detect anxiety.PLoS One. 2019 Sep 9;14(9):e0221894. doi: 10.1371/journal.pone.0221894. eCollection 2019.
186 Thalamic Control of Cognition and Social Behavior Via Regulation of Gamma-Aminobutyric Acidergic Signaling and Excitation/Inhibition Balance in the Medial Prefrontal Cortex.Biol Psychiatry. 2018 Apr 15;83(8):657-669. doi: 10.1016/j.biopsych.2017.11.033. Epub 2017 Dec 7.
187 Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics.Am J Med Genet B Neuropsychiatr Genet. 2004 Apr 1;126B(1):23-36. doi: 10.1002/ajmg.b.20138.
188 CHRNA7 copy number gains are enriched in adolescents with major depressive and anxiety disorders.J Affect Disord. 2018 Oct 15;239:247-252. doi: 10.1016/j.jad.2018.07.017. Epub 2018 Jul 11.
189 miR-219 attenuates demyelination in cuprizone-induced demyelinated mice by regulating monocarboxylate transporter 1.Eur J Neurosci. 2017 Jan;45(2):249-259. doi: 10.1111/ejn.13485.
190 Psychological and emotional development, intellectual capabilities, and body image in short normal children.J Endocrinol Invest. 2002 Apr;25(4):321-8. doi: 10.1007/BF03344012.
191 Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP.PLoS One. 2008;3(10):e3620. doi: 10.1371/journal.pone.0003620. Epub 2008 Oct 31.
192 CRY2 genetic variants associate with dysthymia.PLoS One. 2013 Aug 8;8(8):e71450. doi: 10.1371/journal.pone.0071450. eCollection 2013.
193 The association of schizophrenia risk D-amino acid oxidase polymorphisms with sensorimotor gating, working memory and personality in healthy males.Neuropsychopharmacology. 2011 Jul;36(8):1677-88. doi: 10.1038/npp.2011.49. Epub 2011 Apr 6.
194 Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine -hydroxylase and is associated with abnormal adaptive responses to immobilization stress.Exp Neurol. 2014 Feb;252:63-74. doi: 10.1016/j.expneurol.2013.11.009. Epub 2013 Nov 16.
195 Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice.Sci Rep. 2017 Apr 4;7(1):619. doi: 10.1038/s41598-017-00682-y.
196 The effect of expressive writing on the error-related negativity among individuals with chronic worry.Psychophysiology. 2018 Feb;55(2):10.1111/psyp.12990. doi: 10.1111/psyp.12990. Epub 2017 Sep 8.
197 Intranasal fentanyl and inhaled nitrous oxide for fracture reduction: The FAN observational study.Am J Emerg Med. 2017 May;35(5):710-715. doi: 10.1016/j.ajem.2017.01.004. Epub 2017 Jan 5.
198 Hsp90 Heterocomplexes Regulate Steroid Hormone Receptors: From Stress Response to Psychiatric Disease.Int J Mol Sci. 2018 Dec 25;20(1):79. doi: 10.3390/ijms20010079.
199 Preliminary Data on Some Behavioral Changes Induced by Short-Term Intraperitoneal Oxytocin Administration in Aged Rats.Psychiatr Danub. 2018 Mar;30(1):91-98. doi: 10.24869/psyd.2018.91.
200 Dorsal hippocampal galanin modulates anxiety-like behaviours in rats.Brain Res. 2018 May 15;1687:74-81. doi: 10.1016/j.brainres.2018.02.036. Epub 2018 Feb 27.
201 A Novel Integrative Mechanism in Anxiolytic Behavior Induced by Galanin 2/Neuropeptide Y Y1 Receptor Interactions on Medial Paracapsular Intercalated Amygdala in Rats.Front Cell Neurosci. 2018 May 1;12:119. doi: 10.3389/fncel.2018.00119. eCollection 2018.
202 GPER1/GPR30 in the brain: Crosstalk with classical estrogen receptors and implications for behavior.J Steroid Biochem Mol Biol. 2018 Feb;176:57-64. doi: 10.1016/j.jsbmb.2017.04.012. Epub 2017 Apr 29.
203 No association of GPNMB rs156429 polymorphism with Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese population.Neurosci Lett. 2016 May 27;622:113-7. doi: 10.1016/j.neulet.2016.04.060. Epub 2016 Apr 27.
204 The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress.Mol Brain. 2017 Aug 11;10(1):38. doi: 10.1186/s13041-017-0318-7.
205 The effects of alcoholism on the human basolateral amygdala.Neuroscience. 2010 May 5;167(2):361-71. doi: 10.1016/j.neuroscience.2010.01.061. Epub 2010 Feb 11.
206 Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes.Transl Psychiatry. 2019 Feb 4;9(1):75. doi: 10.1038/s41398-019-0415-8.
207 The Role of 11-Hydroxy Steroid Dehydrogenase Type 2 in Glucocorticoid Programming of Affective and Cognitive Behaviours.Neuroendocrinology. 2019;109(3):257-265. doi: 10.1159/000499660. Epub 2019 Mar 19.
208 Serotonin 2A receptor (5-HT2A) gene promoter variant interacts with chronic perceived stress to modulate resting parasympathetic activity in humans.Psychoneuroendocrinology. 2017 Feb;76:119-126. doi: 10.1016/j.psyneuen.2016.11.015. Epub 2016 Nov 16.
209 Dorsomedial prefrontal cortex 5-HT6 receptors regulate anxiety-like behavior.Cogn Affect Behav Neurosci. 2018 Feb;18(1):58-67. doi: 10.3758/s13415-017-0552-6.
210 Huntingtin gene repeat size variations affect risk of lifetime depression.Transl Psychiatry. 2017 Dec 11;7(12):1277. doi: 10.1038/s41398-017-0042-1.
211 Hippocampus-specific deficiency of IL-15R contributes to greater anxiety-like behaviors in mice.Metab Brain Dis. 2017 Apr;32(2):297-302. doi: 10.1007/s11011-016-9930-y. Epub 2016 Nov 11.
212 A multi-dimensional characterization of anxiety in monozygotic twin pairs reveals susceptibility loci in humans.Transl Psychiatry. 2017 Dec 11;7(12):1282. doi: 10.1038/s41398-017-0047-9.
213 Perseveration in a spatial-discrimination serial reversal learning task is differentially affected by MAO-A and MAO-B inhibition and associated with reduced anxiety and peripheral serotonin levels.Psychopharmacology (Berl). 2017 May;234(9-10):1557-1571. doi: 10.1007/s00213-017-4569-x. Epub 2017 Mar 2.
214 Anesthetic efficacy of the inferior alveolar nerve block in red-haired women.J Endod. 2012 Dec;38(12):1564-9. doi: 10.1016/j.joen.2012.08.014. Epub 2012 Oct 3.
215 Exercise Attenuates Anabolic Steroids-Induced Anxiety via Hippocampal NPY and MC4 Receptor in Rats.Front Neurosci. 2019 Feb 26;13:172. doi: 10.3389/fnins.2019.00172. eCollection 2019.
216 Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists.Life Sci. 2007 Jul 19;81(6):423-40. doi: 10.1016/j.lfs.2007.05.029. Epub 2007 Jun 27.
217 Loss of MeCP2 in adult 5-HT neurons induces 5-HT1A autoreceptors, with opposite sex-dependent anxiety and depression phenotypes.Sci Rep. 2018 Apr 10;8(1):5788. doi: 10.1038/s41598-018-24167-8.
218 Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.Int J Neuropsychopharmacol. 2019 Feb 1;22(2):165-172. doi: 10.1093/ijnp/pyy086.
219 Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E.Nat Commun. 2018 Jun 25;9(1):2459. doi: 10.1038/s41467-018-04883-5.
220 Pharmacotherapy for mood and anxiety disorders in older people with intellectual disability in comparison with the general population.BMC Psychiatry. 2019 Aug 1;19(1):238. doi: 10.1186/s12888-019-2191-7.
221 A Rodent Model of Anxiety: The Effect of Perinatal Immune Challenges on Gastrointestinal Inflammation and Integrity.Neuroimmunomodulation. 2018;25(3):163-175. doi: 10.1159/000493320. Epub 2018 Nov 9.
222 NPTX2 is a key component in the regulation of anxiety.Neuropsychopharmacology. 2018 Aug;43(9):1943-1953. doi: 10.1038/s41386-018-0091-z. Epub 2018 May 11.
223 Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice.J Mol Neurosci. 2006;28(3):239-45. doi: 10.1385/JMN:28:3:239.
224 Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants.Am J Med Genet B Neuropsychiatr Genet. 2008 Jun 5;147B(4):510-6. doi: 10.1002/ajmg.b.30629.
225 Loss of quinone reductase 2 function selectively facilitates learning behaviors.J Neurosci. 2010 Sep 22;30(38):12690-700. doi: 10.1523/JNEUROSCI.2808-10.2010.
226 The circadian gene Nr1d1 in the mouse nucleus accumbens modulates sociability and anxiety-related behavior.Eur J Neurosci. 2018 Oct 16. doi: 10.1111/ejn.14207. Online ahead of print.
227 Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders.Hum Mutat. 2009 Jul;30(7):1062-71. doi: 10.1002/humu.21005.
228 Activation of kappa opioid receptors in the dorsal raphe have sex dependent effects on social behavior in California mice.Behav Brain Res. 2018 Oct 1;351:83-92. doi: 10.1016/j.bbr.2018.05.011. Epub 2018 Jun 7.
229 Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders.J Affect Disord. 2007 Aug;101(1-3):159-68. doi: 10.1016/j.jad.2006.11.016. Epub 2007 Jan 2.
230 Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms.Transl Psychiatry. 2011 May 24;1(5):e9. doi: 10.1038/tp.2011.9.
231 Phosphodiesterase-7 inhibition affects accumbal and hypothalamic thyrotropin-releasing hormone expression, feeding and anxiety behavior of rats.Behav Brain Res. 2017 Feb 15;319:165-173. doi: 10.1016/j.bbr.2016.11.027. Epub 2016 Nov 15.
232 Brain Vitamin E Deficiency During Development Is Associated With Increased Glutamate Levels and Anxiety in Adult Mice.Front Behav Neurosci. 2018 Dec 11;12:310. doi: 10.3389/fnbeh.2018.00310. eCollection 2018.
233 Contagious Anxiety: Anxious European Americans Can Transmit Their Physiological Reactivity to African Americans.Psychol Sci. 2017 Dec;28(12):1796-1806. doi: 10.1177/0956797617722551. Epub 2017 Nov 6.
234 15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse.Neuropharmacology. 2014 Jan;76 Pt B(0 0):204-17. doi: 10.1016/j.neuropharm.2013.08.028. Epub 2013 Sep 10.
235 Appetite Perceptions, Gastrointestinal Symptoms, Ghrelin, Peptide YY and State Anxiety Are Disturbed in Adolescent Females with Anorexia Nervosa and Only Partially Restored with Short-Term Refeeding.Nutrients. 2018 Dec 28;11(1):59. doi: 10.3390/nu11010059.
236 Attention Deficit Hyperactivity Disorder in Pediatric Patients with Pheochromocytoma and Paraganglioma.Horm Metab Res. 2016 Aug;48(8):509-13. doi: 10.1055/s-0042-106725. Epub 2016 May 12.
237 Impacts of dance on cognition, psychological symptoms and quality of life in Parkinson's disease.NeuroRehabilitation. 2019;45(2):273-283. doi: 10.3233/NRE-192788.
238 Self-reported physical activity levels and clinical progression in early Parkinson's disease.Parkinsonism Relat Disord. 2019 Apr;61:118-125. doi: 10.1016/j.parkreldis.2018.11.006. Epub 2018 Dec 10.
239 Sigma-1 receptor activation ameliorates anxiety-like behavior through NR2A-CREB-BDNF signaling pathway in a rat model submitted to single-prolonged stress.Mol Med Rep. 2017 Oct;16(4):4987-4993. doi: 10.3892/mmr.2017.7185. Epub 2017 Aug 7.
240 A Functional Vesicular Monoamine Transporter 1 (VMAT1) Gene Variant Is Associated with Affect and the Prevalence of Anxiety, Affective, and Alcohol Use Disorders in a Longitudinal Population-Representative Birth Cohort Study.Int J Neuropsychopharmacol. 2016 Jul 5;19(7):pyw013. doi: 10.1093/ijnp/pyw013. Print 2016 Jul.
241 Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice.Biol Res. 2017 Sep 19;50(1):29. doi: 10.1186/s40659-017-0138-3.
242 Associations of serum uric acid and SLC2A9 variant with depressive and anxiety disorders: a population-based study.PLoS One. 2013 Oct 29;8(10):e76336. doi: 10.1371/journal.pone.0076336. eCollection 2013.
243 Angiotensin as stress mediator: role of its receptor and interrelationships among other stress mediators and receptors.Pharmacol Res. 2013 Oct;76:49-57. doi: 10.1016/j.phrs.2013.07.004. Epub 2013 Jul 24.
244 Positive association between SAT-1 -1415T/C polymorphism and anxiety.Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):515-9. doi: 10.1002/ajmg.b.30850.
245 Studies on the Activity of Selected Highly Lipophilic Compounds toward hGAT1 Inhibition. Part II.ACS Chem Neurosci. 2019 Jan 16;10(1):337-347. doi: 10.1021/acschemneuro.8b00282. Epub 2018 Sep 28.
246 Excess costs of social anxiety disorder in Germany.J Affect Disord. 2017 Apr 15;213:23-29. doi: 10.1016/j.jad.2017.01.041. Epub 2017 Feb 2.
247 Gender-specific association of variants in the AKR1C1 gene with dimensional anxiety in patients with panic disorder: additional evidence for the importance of neurosteroids in anxiety?.Depress Anxiety. 2014 Oct;31(10):843-50. doi: 10.1002/da.22229. Epub 2014 Jan 3.
248 The Case for TAAR1 as a Modulator of Central Nervous System Function.Front Pharmacol. 2018 Jan 10;8:987. doi: 10.3389/fphar.2017.00987. eCollection 2017.
249 Modulation of Hippocampal Antioxidant Defense System in Chronically Stressed Rats by Lithium.Oxid Med Cell Longev. 2019 Feb 17;2019:8745376. doi: 10.1155/2019/8745376. eCollection 2019.
250 Properties and therapeutic potential of transient receptor potential channels with putative roles in adversity: focus on TRPC5, TRPM2 and TRPA1.Curr Drug Targets. 2011 May;12(5):724-36. doi: 10.2174/138945011795378568.
251 Do family functioning and mothers' and children's stress increase the odds of probable sleep bruxism among schoolchildren? A case control study.Clin Oral Investig. 2020 Feb;24(2):1025-1033. doi: 10.1007/s00784-019-02997-8. Epub 2019 Jul 8.
252 Genetic markers of a Munc13 protein family member, BAIAP3, are gender specifically associated with anxiety and benzodiazepine abuse in mice and humans.Mol Med. 2013 Jul 24;19(1):135-48. doi: 10.2119/molmed.2013.00033.
253 Functional effects of synthetic cannabinoids versus (9) -THC in mice on body temperature, nociceptive threshold, anxiety, cognition, locomotor/exploratory parameters and depression.Addict Biol. 2019 May;24(3):414-425. doi: 10.1111/adb.12606. Epub 2018 Feb 8.
254 Decreasing the Expression of GABA(A) 5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.Mol Neurobiol. 2018 Jun;55(6):4745-4762. doi: 10.1007/s12035-017-0675-3. Epub 2017 Jul 17.
255 Kainate receptor mediated presynaptic LTP in agranular insular cortex contributes to fear and anxiety in mice.Neuropharmacology. 2018 Jan;128:388-400. doi: 10.1016/j.neuropharm.2017.10.037. Epub 2017 Nov 12.
256 Religiosity prevalence and its association with depression and anxiety symptoms among Hispanic/Latino adults.PLoS One. 2018 Feb 7;13(2):e0185661. doi: 10.1371/journal.pone.0185661. eCollection 2018.
257 Desacyl Ghrelin Decreases Anxiety-like Behavior in Male Mice.Endocrinology. 2018 Jan 1;159(1):388-399. doi: 10.1210/en.2017-00540.
258 Novelty response of rats determines the effect of prefrontal alpha-2 adrenoceptor modulation on anxiety.Neurosci Lett. 2011 Jul 25;499(3):219-23. doi: 10.1016/j.neulet.2011.05.231. Epub 2011 Jun 6.
259 The aldehyde dehydrogenase 2 polymorphisms on neuropsychological performance in bipolar II disorder with or without comorbid anxiety disorder.PLoS One. 2018 Feb 9;13(2):e0192229. doi: 10.1371/journal.pone.0192229. eCollection 2018.
260 Mobile phone induced cognitive and neurochemical consequences.J Chem Neuroanat. 2019 Dec;102:101684. doi: 10.1016/j.jchemneu.2019.101684. Epub 2019 Sep 22.
261 Gestational hypoxia induces sex-differential methylation of Crhr1 linked to anxiety-like behavior.Mol Neurobiol. 2013 Dec;48(3):544-55. doi: 10.1007/s12035-013-8444-4. Epub 2013 Mar 26.
262 Estrogen receptor activation within dorsal raphe nucleus reverses anxiety-like behavior induced by food restriction in female rats.Behav Brain Res. 2019 Jan 14;357-358:57-64. doi: 10.1016/j.bbr.2018.03.029. Epub 2018 Mar 19.
263 Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats.Neuropharmacology. 2019 Apr;148:311-319. doi: 10.1016/j.neuropharm.2019.01.026. Epub 2019 Jan 25.
264 "Juvenile stress" alters maturation-related changes in expression of the neural cell adhesion molecule L1 in the limbic system: relevance for stress-related psychopathologies.J Neurosci Res. 2010 Feb 1;88(2):369-80. doi: 10.1002/jnr.22203.
265 Genetic Variants Associated With Anxiety and Stress-Related Disorders: A Genome-Wide Association Study and Mouse-Model Study.JAMA Psychiatry. 2019 Sep 1;76(9):924-932. doi: 10.1001/jamapsychiatry.2019.1119.
266 PACAP receptor gene polymorphism impacts fear responses in the amygdala and hippocampus.Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3158-63. doi: 10.1073/pnas.1318954111. Epub 2014 Feb 10.
267 RGS2 ggenetic variation: association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxiety.Am J Med Genet B Neuropsychiatr Genet. 2015 Apr;168B(3):211-22. doi: 10.1002/ajmg.b.32299. Epub 2015 Mar 4.
268 Overexpression of tissue-nonspecific alkaline phosphatase increases the expression of neurogenic differentiation markers in the human SH-SY5Y neuroblastoma cell line.Bone. 2015 Oct;79:150-61. doi: 10.1016/j.bone.2015.05.033. Epub 2015 May 29.
269 Profiles and Predictors of Infant Sleep Problems Across the First Year.J Dev Behav Pediatr. 2020 Feb/Mar;41(2):104-116. doi: 10.1097/DBP.0000000000000733.
270 Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor.Am J Physiol Regul Integr Comp Physiol. 2019 Aug 1;317(2):R289-R300. doi: 10.1152/ajpregu.00029.2019. Epub 2019 Apr 24.
271 Maternal stress during pregnancy induces depressive-like behavior only in female offspring and correlates to their hippocampal Avp and Oxt receptor expression.Behav Brain Res. 2018 Nov 1;353:1-10. doi: 10.1016/j.bbr.2018.06.027. Epub 2018 Jun 26.
272 Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.Br J Pharmacol. 2014 Jul;171(14):3511-25. doi: 10.1111/bph.12699.
273 A Pilot Randomized Controlled Trial of a Guided Self-Help Intervention to Manage Chronic Orofacial Pain.J Oral Facial Pain Headache. 2017 Winter;31(1):61-71. doi: 10.11607/ofph.1665.
274 Cholecystokinin system genes: associations with panic and other psychiatric disorders.J Affect Disord. 2012 Feb;136(3):902-8. doi: 10.1016/j.jad.2011.09.011. Epub 2011 Oct 5.
275 Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia. Eur J Neurosci. 2005 Mar;21(6):1712-8. doi: 10.1111/j.1460-9568.2005.04002.x.
276 Genome-wide analyses of borderline personality features.Mol Psychiatry. 2014 Aug;19(8):923-9. doi: 10.1038/mp.2013.109. Epub 2013 Aug 27.
277 Alpha-7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide-induced anxiety, cognitive deficit and depression-like behaviors in mice.Behav Brain Res. 2019 Jul 2;366:19-28. doi: 10.1016/j.bbr.2019.03.019. Epub 2019 Mar 12.
278 Knockout of alpha 5 nicotinic acetylcholine receptors subunit alters ethanol-mediated behavioral effects and reward in mice.Neuropharmacology. 2018 Aug;138:341-348. doi: 10.1016/j.neuropharm.2018.06.031. Epub 2018 Jun 23.
279 The 2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse.Alcohol. 2013 Mar;47(2):85-94. doi: 10.1016/j.alcohol.2012.12.004.
280 A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes.J Affect Disord. 2019 Oct 1;257:716-722. doi: 10.1016/j.jad.2019.07.083. Epub 2019 Jul 30.
281 Ciliary neurotrophic factor is a key sex-specific regulator of depressive-like behavior in mice.Psychoneuroendocrinology. 2019 Feb;100:96-105. doi: 10.1016/j.psyneuen.2018.09.038. Epub 2018 Sep 29.
282 Helicobacter pylori Vacuolating Cytotoxin A Causes Anorexia and Anxiety via Hypothalamic Urocortin 1 in Mice.Sci Rep. 2019 Apr 12;9(1):6011. doi: 10.1038/s41598-019-42163-4.
283 Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders.Front Pharmacol. 2019 Feb 19;10:99. doi: 10.3389/fphar.2019.00099. eCollection 2019.
284 Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder.Medicine (Baltimore). 2016 Feb;95(6):e2473. doi: 10.1097/MD.0000000000002473.
285 Persistent overexpression of DNA methyltransferase 1 attenuating GABAergic inhibition in basolateral amygdala accounts for anxiety in rat offspring exposed perinatally to low-dose bisphenol A.J Psychiatr Res. 2013 Oct;47(10):1535-44. doi: 10.1016/j.jpsychires.2013.05.013. Epub 2013 Jun 20.
286 Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.PLoS One. 2019 Jun 10;14(6):e0217314. doi: 10.1371/journal.pone.0217314. eCollection 2019.
287 Association of high-fat diet with neuroinflammation, anxiety-like defensive behavioral responses, and altered thermoregulatory responses in male rats.Brain Behav Immun. 2019 Aug;80:500-511. doi: 10.1016/j.bbi.2019.04.030. Epub 2019 Apr 22.
288 A ghrelin receptor and oxytocin receptor heterocomplex impairs oxytocin mediated signalling.Neuropharmacology. 2019 Jul 1;152:90-101. doi: 10.1016/j.neuropharm.2018.12.022. Epub 2018 Dec 21.
289 Amygdala levels of the GluA1 subunit of glutamate receptors and its phosphorylation state at serine 845 in the anterior hippocampus are biomarkers of ictal fear but not anxiety.Mol Psychiatry. 2020 Mar;25(3):655-665. doi: 10.1038/s41380-018-0084-7. Epub 2018 Jun 7.
290 Applying ketamine to alleviate the PTSD-like effects by regulating the HCN1-related BDNF.Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:313-321. doi: 10.1016/j.pnpbp.2018.03.019. Epub 2018 Mar 27.
291 Association of polymorphisms in HCN4 with mood disorders and obsessive compulsive disorder.Neurosci Lett. 2011 Jun 8;496(3):195-9. doi: 10.1016/j.neulet.2011.04.026. Epub 2011 Apr 20.
292 Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy.Brain Res. 2020 Mar 15;1731:146085. doi: 10.1016/j.brainres.2018.12.036. Epub 2018 Dec 24.
293 Lactate is an antidepressant that mediates resilience to stress by modulating the hippocampal levels and activity of histone deacetylases.Neuropsychopharmacology. 2019 May;44(6):1152-1162. doi: 10.1038/s41386-019-0313-z. Epub 2019 Jan 8.
294 Serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder in Chinese Han subjects.Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):59-63. doi: 10.1002/ajmg.b.30075.
295 Response of Htr3a knockout mice to antidepressant treatment and chronic stress.Br J Pharmacol. 2017 Aug;174(15):2471-2483. doi: 10.1111/bph.13857. Epub 2017 Jul 5.
296 Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation. Acta Neuropsychiatr. 2020 Feb;32(1):43-53.
297 Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C.Psychosomatics. 2002 Sep-Oct;43(5):378-85. doi: 10.1176/appi.psy.43.5.378.
298 The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders.Am J Med Genet B Neuropsychiatr Genet. 2014 Mar;165B(2):175-83. doi: 10.1002/ajmg.b.32219. Epub 2014 Jan 16.
299 Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.Hum Mol Genet. 2018 Aug 15;27(16):2874-2892. doi: 10.1093/hmg/ddy201.
300 Dopaminergic hypofunctions and prepulse inhibition deficits in mice lacking midkine.Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30;33(3):541-6. doi: 10.1016/j.pnpbp.2009.02.005. Epub 2009 Feb 13.
301 The long-term effects of microvascular decompression on social phobia and health-related quality of life in patients with hemifacial spasm: a 3-year prospective study.Acta Neurochir (Wien). 2019 Oct;161(10):2035-2042. doi: 10.1007/s00701-019-04023-y. Epub 2019 Jul 31.
302 Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance.Tumori. 2018 Jun;104(3):172-178. doi: 10.5301/tj.5000646. Epub 2018 May 9.
303 Investigating the Contribution of NPSR1, IL-6 and BDNF Polymorphisms to Depressive and Anxiety Symptoms in Hemodialysis Patients.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Aug 30;94:109657. doi: 10.1016/j.pnpbp.2019.109657. Epub 2019 May 25.
304 Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions.Brain Struct Funct. 2015 Jul;220(4):2289-301. doi: 10.1007/s00429-014-0788-7. Epub 2014 May 20.
305 Ablation of glucocorticoid receptor in the hindbrain of the mouse provides a novel model to investigate stress disorders.Sci Rep. 2019 Mar 1;9(1):3250. doi: 10.1038/s41598-019-39867-y.
306 Sleep-EEG in patients with primary aldosteronism in comparison to healthy controls and patients with depression.J Psychiatr Res. 2019 May;112:52-60. doi: 10.1016/j.jpsychires.2019.02.020. Epub 2019 Feb 23.
307 Ca(2+)-dependent activator protein for secretion 2 and autistic-like phenotypes.Neurosci Res. 2010 Jul;67(3):197-202. doi: 10.1016/j.neures.2010.03.006. Epub 2010 Mar 17.
308 Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment.Subst Use Misuse. 2019;54(10):1589-1598. doi: 10.1080/10826084.2018.1552298. Epub 2019 May 26.
309 Interaction between the Opioid Receptor OPRM1 Gene and Mother-Child Language Style Matching Prospectively Predicts Children's Separation Anxiety Disorder Symptoms.Res Dev Disabil. 2018 Nov;82:120-131. doi: 10.1016/j.ridd.2018.03.002. Epub 2018 Mar 22.
310 Oxytocin receptor gene methylation in male and female PTSD patients and trauma-exposed controls.Eur Neuropsychopharmacol. 2019 Jan;29(1):147-155. doi: 10.1016/j.euroneuro.2018.10.006. Epub 2018 Nov 8.
311 Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.J Neuroinflammation. 2017 May 10;14(1):102. doi: 10.1186/s12974-017-0865-y.
312 Interactions of peptide amidation and copper: novel biomarkers and mechanisms of neural dysfunction.Neurobiol Dis. 2010 Jan;37(1):130-40. doi: 10.1016/j.nbd.2009.09.016. Epub 2009 Oct 6.
313 Expression and significance of phosphodiesterase 4B gene in peripheral blood of patients with oral lichen planus.Int J Dermatol. 2019 Mar;58(3):302-310. doi: 10.1111/ijd.14203. Epub 2018 Sep 19.
314 Phf8 loss confers resistance to depression-like and anxiety-like behaviors in mice.Nat Commun. 2017 May 9;8:15142. doi: 10.1038/ncomms15142.
315 Loss-of-function of PTPR and , observed in sporadic schizophrenia, causes brain region-specific deregulation of monoamine levels and altered behavior in mice.Psychopharmacology (Berl). 2017 Feb;234(4):575-587. doi: 10.1007/s00213-016-4490-8. Epub 2016 Dec 26.
316 Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac.Transl Psychiatry. 2016 Sep 6;6(9):e881. doi: 10.1038/tp.2016.129.
317 Interplay between RGS2 and childhood adversities in predicting anxiety and depressive disorders: Findings from a general population sample.Depress Anxiety. 2018 Nov;35(11):1104-1113. doi: 10.1002/da.22812. Epub 2018 Aug 14.
318 Intranasal administration of a stapled relaxin-3 mimetic has anxiolytic- and antidepressant-like activity in rats.Br J Pharmacol. 2019 Oct;176(20):3899-3923. doi: 10.1111/bph.14774. Epub 2019 Sep 11.
319 Ethanol (EtOH)-Related Behaviors in -Synuclein Mutant Mice and Association of SNCA SNPs with Anxiety in EtOH-Dependent Patients.Alcohol Clin Exp Res. 2018 Nov;42(11):2172-2185. doi: 10.1111/acer.13875. Epub 2018 Sep 5.
320 Alcohol-induced conditioned place preference negatively correlates with anxiety-like behavior in adolescent mice: inhibition by a neurokinin-1 receptor antagonist.Psychopharmacology (Berl). 2018 Oct;235(10):2847-2857. doi: 10.1007/s00213-018-4976-7. Epub 2018 Jul 27.
321 Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.Hum Mol Genet. 2013 Sep 1;22(17):3485-97. doi: 10.1093/hmg/ddt203. Epub 2013 May 22.
322 Association analysis of monoamine genes with measures of depression and anxiety in a selected community sample of siblings.Am J Med Genet B Neuropsychiatr Genet. 2005 May 5;135B(1):33-7. doi: 10.1002/ajmg.b.30063.
323 Kinesiophobia and depression affect total knee arthroplasty outcome in a multivariate analysis of psychological and physical factors on 200 patients.Knee Surg Sports Traumatol Arthrosc. 2017 Nov;25(11):3417-3423. doi: 10.1007/s00167-016-4201-3. Epub 2016 Jun 21.
324 AGRP neurons modulate fasting-induced anxiolytic effects.Transl Psychiatry. 2019 Mar 8;9(1):111. doi: 10.1038/s41398-019-0438-1.
325 Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.J Alzheimers Dis. 2018;65(1):147-163. doi: 10.3233/JAD-180053.
326 Caspase-2 promotes AMPA receptor internalization and cognitive flexibility via mTORC2-AKT-GSK3 signaling.Nat Commun. 2019 Aug 9;10(1):3622. doi: 10.1038/s41467-019-11575-1.
327 Early intervention with electroacupuncture prevents PTSD-like behaviors in rats through enhancing hippocampal endocannabinoid signaling.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 13;93:171-181. doi: 10.1016/j.pnpbp.2019.03.018. Epub 2019 Apr 1.
328 Toxicity of Pexacerfont, a Corticotropin-Releasing Factor Type 1 Receptor Antagonist, in Rats and Dogs.Int J Toxicol. 2019 Mar/Apr;38(2):110-120. doi: 10.1177/1091581819827501. Epub 2019 Feb 13.
329 Blocking CRH receptors in adults mitigates age-related memory impairments provoked by early-life adversity.Neuropsychopharmacology. 2020 Feb;45(3):515-523. doi: 10.1038/s41386-019-0562-x. Epub 2019 Nov 7.
330 Biological and psychosocial predictors of anxiety worsening in the postpartum period: A longitudinal study.J Affect Disord. 2019 May 1;250:218-225. doi: 10.1016/j.jad.2019.02.064. Epub 2019 Mar 1.
331 Effect of lacosamide on ethanol induced conditioned place preference and withdrawal associated behavior in mice: Possible contribution of hippocampal CRMP-2.Pharmacol Rep. 2019 Oct;71(5):804-810. doi: 10.1016/j.pharep.2019.04.009. Epub 2019 Apr 15.
332 Synergistic effects between ADORA2A and DRD2 genes on anxiety disorders in children with ADHD.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 13;93:214-220. doi: 10.1016/j.pnpbp.2019.03.021. Epub 2019 Apr 1.
333 Developmental seizures and mortality result from reducing GABA(A) receptor 2-subunit interaction with collybistin.Nat Commun. 2018 Aug 7;9(1):3130. doi: 10.1038/s41467-018-05481-1.
334 Anxiety process "theta" biomarker in the stop signal task eliminated by a preceding relaxation test.Behav Neurosci. 2020 Dec;134(6):556-561. doi: 10.1037/bne0000328. Epub 2019 Jun 20.
335 Measuring Anxiety in Older Adults: Development, Diagnostic Accuracy, and Preliminary Validation of a Short-Form of the German Geriatric Anxiety Scale (GAS-G-SF).J Pers Assess. 2020 Mar-Apr;102(2):196-204. doi: 10.1080/00223891.2019.1677679. Epub 2019 Oct 18.
336 More than reproduction: Central gonadotropin-releasing hormone antagonism decreases maternal aggression in lactating rats.J Neuroendocrinol. 2019 Sep;31(9):e12709. doi: 10.1111/jne.12709. Epub 2019 Apr 4.
337 An Appraisal of the Influence of the Metabotropic Glutamate 5 (mGlu5) Receptor on Sociability and Anxiety.Front Mol Neurosci. 2019 Feb 19;12:30. doi: 10.3389/fnmol.2019.00030. eCollection 2019.
338 Anxiety-like behavior in female mice changes by feeding, possible effect of guanylate cyclase C.Eur J Neurosci. 2020 Jul;52(1):2781-2790. doi: 10.1111/ejn.14607. Epub 2019 Nov 28.
339 Macrophage migration inhibitory factor (MIF) gene is associated with adolescents' cortisol reactivity and anxiety.Psychoneuroendocrinology. 2018 Sep;95:170-178. doi: 10.1016/j.psyneuen.2018.05.033. Epub 2018 May 26.
340 Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice.J Psychopharmacol. 2019 May;33(5):568-576. doi: 10.1177/0269881119832753. Epub 2019 Mar 5.
341 Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse?.Neurotoxicology. 2007 Sep;28(5):899-914. doi: 10.1016/j.neuro.2007.05.011. Epub 2007 Jun 14.
342 SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV.J Antimicrob Chemother. 2019 Apr 1;74(4):1035-1043. doi: 10.1093/jac/dky508.
343 TRPM2 ion channel is involved in the aggravation of cognitive impairment and down regulation of epilepsy threshold in pentylenetetrazole-induced kindling mice.Brain Res Bull. 2020 Feb;155:48-60. doi: 10.1016/j.brainresbull.2019.11.018. Epub 2019 Nov 30.
344 Differential expression of VGLUT3 in laboratory mouse strains: Impact on drug-induced hyperlocomotion and anxiety-related behaviors.Genes Brain Behav. 2019 Mar;18(3):e12528. doi: 10.1111/gbb.12528. Epub 2018 Nov 6.
345 Correcting miR92a-vGAT-Mediated GABAergic Dysfunctions Rescues Human Tau-Induced Anxiety in Mice.Mol Ther. 2017 Jan 4;25(1):140-152. doi: 10.1016/j.ymthe.2016.10.010. Epub 2017 Jan 4.
346 VGluT1 Deficiency Impairs Visual Attention and Reduces the Dynamic Range of Short-Term Plasticity at Corticothalamic Synapses.Cereb Cortex. 2020 Mar 14;30(3):1813-1829. doi: 10.1093/cercor/bhz204.
347 Fibromyalgia, mood disorders, and intense creative energy: A1AT polymorphisms are not always silent.Neurotoxicology. 2012 Dec;33(6):1454-1472. doi: 10.1016/j.neuro.2012.03.001. Epub 2012 Mar 10.
348 An Extract of Artemisia dracunculus L. Promotes Psychological Resilience in a Mouse Model of Depression.Oxid Med Cell Longev. 2018 May 13;2018:7418681. doi: 10.1155/2018/7418681. eCollection 2018.
349 A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects.Biol Psychiatry. 2009 Jun 15;65(12):1063-70. doi: 10.1016/j.biopsych.2009.01.003. Epub 2009 Feb 20.
350 The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety.Cureus. 2018 Aug 13;10(8):e3133. doi: 10.7759/cureus.3133.
351 Discovery and validation of blood biomarkers for suicidality.Mol Psychiatry. 2013 Dec;18(12):1249-64. doi: 10.1038/mp.2013.95. Epub 2013 Aug 20.
352 Genetic alcohol sensitivity regulated by ALDH2 and ADH1B polymorphisms is strongly associated with depression and anxiety in Japanese employees.Drug Alcohol Depend. 2015 Feb 1;147:130-6. doi: 10.1016/j.drugalcdep.2014.11.034. Epub 2014 Dec 13.
353 FAAH-Catalyzed C-C Bond Cleavage of a New Multitarget Analgesic Drug.ACS Chem Neurosci. 2019 Jan 16;10(1):424-437. doi: 10.1021/acschemneuro.8b00315. Epub 2018 Oct 4.
354 Precision medicine for suicidality: from universality to subtypes and personalization.Mol Psychiatry. 2017 Sep;22(9):1250-1273. doi: 10.1038/mp.2017.128. Epub 2017 Aug 15.
355 Assessment of Placental Cortisol Pathway Gene Expression in Term Pregnant Women with Anxiety.Neuropsychobiology. 2019;77(1):1-7. doi: 10.1159/000490428. Epub 2018 Aug 15.
356 Chronic harsh parenting and anxiety associations with fear circuitry function in healthy adolescents: A preliminary study.Biol Psychol. 2019 Jul;145:198-210. doi: 10.1016/j.biopsycho.2019.03.019. Epub 2019 Mar 29.
357 Prospective Study of Psychological Morbidity and Illness Perceptions in Young People With Inflammatory Bowel Disease.J Crohns Colitis. 2019 Aug 14;13(8):1003-1011. doi: 10.1093/ecco-jcc/jjz028.
358 Longitudinal Magnetic Resonance Imaging Analysis and Histological Characterization after Spinal Cord Injury in Two Mouse Strains with Different Functional Recovery: Gliosis as a Key Factor.J Neurotrauma. 2018 Dec 15;35(24):2924-2940. doi: 10.1089/neu.2017.5613. Epub 2018 Aug 10.
359 MAOA interacts with the ALDH2 gene in anxiety-depression alcohol dependence.Alcohol Clin Exp Res. 2010 Jul;34(7):1212-8. doi: 10.1111/j.1530-0277.2010.01198.x. Epub 2010 May 7.
360 What Comes First Metacognition or Negative Emotion? A Test of Temporal Precedence.Front Psychol. 2019 Nov 19;10:2507. doi: 10.3389/fpsyg.2019.02507. eCollection 2019.
361 The association of dopamine pathway gene score, nicotine dependence and smoking cessation in a rural male population of Shandong, China.Am J Addict. 2016 Sep;25(6):493-8. doi: 10.1111/ajad.12421. Epub 2016 Aug 4.
362 Perceived maternal care is associated with emotional eating in young adults.Physiol Behav. 2019 Mar 15;201:91-94. doi: 10.1016/j.physbeh.2018.12.022. Epub 2018 Dec 20.
363 Activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) regulates anxiety- and novelty-related behaviors.Genes Brain Behav. 2019 Sep;18(7):e12561. doi: 10.1111/gbb.12561. Epub 2019 Apr 15.
364 A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation.Hum Mutat. 2009 Jan;30(1):61-8. doi: 10.1002/humu.20814.
365 Blockade of TrkB receptors in the nucleus accumbens prior to heterotypic stress alters corticotropin-releasing hormone (CRH), vesicular glutamate transporter 2 (vGluT2) and glucocorticoid receptor (GR) within the mesolimbic pathway.Horm Behav. 2017 Apr;90:98-112. doi: 10.1016/j.yhbeh.2017.02.012. Epub 2017 Mar 15.
366 Cbln2 and Cbln4 are expressed in distinct medial habenula-interpeduncular projections and contribute to different behavioral outputs.Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10235-E10244. doi: 10.1073/pnas.1811086115. Epub 2018 Oct 4.
367 Developmental effects of serotonin 1A autoreceptors on anxiety and social behavior.Neuropsychopharmacology. 2014 Jan;39(2):291-302. doi: 10.1038/npp.2013.185. Epub 2013 Aug 2.
368 Coping and Anxiety in Caregivers of Dependent Older Adult Relatives.Int J Environ Res Public Health. 2019 May 12;16(9):1651. doi: 10.3390/ijerph16091651.
369 A Clinically Relevant Closed-Head Model of Single and Repeat Concussive Injury in the Adult Rat Using a Controlled Cortical Impact Device.J Neurotrauma. 2017 Apr 1;34(7):1351-1363. doi: 10.1089/neu.2016.4517. Epub 2016 Dec 2.
370 The evaluation of a continuing professional development package for primary care dentists designed to reduce stress, build resilience and improve clinical decision-making.Br Dent J. 2017 Aug 25;223(4):261-271. doi: 10.1038/sj.bdj.2017.712.
371 Anxiolytic effect of CPEB1 knockdown on the amygdala of a mouse model of inflammatory pain.Brain Res Bull. 2018 Mar;137:156-165. doi: 10.1016/j.brainresbull.2017.12.002. Epub 2017 Dec 11.
372 A complex chromosome 7q rearrangement identified in a patient with mental retardation, anxiety disorder, and autistic features.Am J Med Genet A. 2010 Feb;152A(2):427-33. doi: 10.1002/ajmg.a.33203.
373 Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorder.Am J Med Genet B Neuropsychiatr Genet. 2003 Feb;117B(1):70-8. doi: 10.1002/ajmg.b.10018.
374 Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse model.Sci Rep. 2015 Nov 10;5:16300. doi: 10.1038/srep16300.
375 Outcome of depressive and anxiety disorders among young adults: Results from the Longitudinal Finnish Health 2011 Study.Nord J Psychiatry. 2018 Apr;72(3):205-213. doi: 10.1080/08039488.2017.1418429. Epub 2017 Dec 25.
376 Cafeteria-diet effects on cognitive functions, anxiety, fear response and neurogenesis in the juvenile rat.Neurobiol Learn Mem. 2018 Nov;155:197-207. doi: 10.1016/j.nlm.2018.07.014. Epub 2018 Jul 31.
377 Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome.Transl Psychiatry. 2012 Apr 24;2(4):e105. doi: 10.1038/tp.2012.31.
378 Anxiogenic-like behavior and deficient attention/working memory in rats expressing the human DISC1 gene.Pharmacol Biochem Behav. 2019 Apr;179:73-79. doi: 10.1016/j.pbb.2019.02.005. Epub 2019 Feb 16.
379 Behavioral flexibility in a mouse model for obsessive-compulsive disorder: Impaired Pavlovian reversal learning in SAPAP3 mutants.Genes Brain Behav. 2019 Apr;18(4):e12557. doi: 10.1111/gbb.12557. Epub 2019 Feb 27.
380 Deletion of Dlk2 increases the vulnerability to anxiety-like behaviors and impairs the anxiolytic action of alprazolam.Psychoneuroendocrinology. 2017 Nov;85:134-141. doi: 10.1016/j.psyneuen.2017.08.015. Epub 2017 Aug 31.
381 Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder.Psychiatry Res. 2013 Dec 30;210(3):1299-300. doi: 10.1016/j.psychres.2013.07.038. Epub 2013 Aug 22.
382 First genome-wide association study on anxiety-related behaviours in childhood.PLoS One. 2013;8(4):e58676. doi: 10.1371/journal.pone.0058676. Epub 2013 Apr 2.
383 Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease.Parkinsonism Relat Disord. 2017 Aug;41:113-117. doi: 10.1016/j.parkreldis.2017.05.003. Epub 2017 May 8.
384 P11 Loss-of-Function is Associated with Decreased Cell Proliferation and Neurobehavioral Disorders in Mice.Int J Biol Sci. 2019 May 20;15(7):1383-1395. doi: 10.7150/ijbs.33773. eCollection 2019.
385 Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.J Child Adolesc Psychopharmacol. 2017 Feb;27(1):29-37. doi: 10.1089/cap.2016.0132. Epub 2017 Feb 6.
386 A new F-box protein 7 gene mutation causing typical Parkinson's disease.Mov Disord. 2015 Jul;30(8):1130-3. doi: 10.1002/mds.26266. Epub 2015 May 23.
387 Inactivation of fibroblast growth factor binding protein 3 causes anxiety-related behaviors.Mol Cell Neurosci. 2011 Jan;46(1):200-12. doi: 10.1016/j.mcn.2010.09.003. Epub 2010 Sep 21.
388 Foxg1 deletion impairs the development of the epithalamus.Mol Brain. 2018 Feb 2;11(1):5. doi: 10.1186/s13041-018-0350-2.
389 GPR26-deficient mice display increased anxiety- and depression-like behaviors accompanied by reduced phosphorylated cyclic AMP responsive element-binding protein level in central amygdala.Neuroscience. 2011 Nov 24;196:203-14. doi: 10.1016/j.neuroscience.2011.08.069. Epub 2011 Sep 8.
390 Maternal Alexithymia and Attachment Style: Which Relationship with Their Children's Headache Features and Psychological Profile?.Front Neurol. 2018 Jan 22;8:751. doi: 10.3389/fneur.2017.00751. eCollection 2017.
391 Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia.Genes Brain Behav. 2005 Jul;4(5):273-88. doi: 10.1111/j.1601-183X.2005.00120.x.
392 Contribution of health motive to cannabis use among high-school students.Addict Behav. 2017 Jan;64:54-56. doi: 10.1016/j.addbeh.2016.08.011. Epub 2016 Aug 10.
393 IgSF9b regulates anxiety behaviors through effects on centromedial amygdala inhibitory synapses.Nat Commun. 2018 Dec 20;9(1):5400. doi: 10.1038/s41467-018-07762-1.
394 MicroRNA hsa-miR-4717-5p regulates RGS2 and may be a risk factor for anxiety-related traits.Am J Med Genet B Neuropsychiatr Genet. 2015 Jun;168B(4):296-306. doi: 10.1002/ajmg.b.32312. Epub 2015 Apr 2.
395 Biopsychosocial influence on exercise-induced injury: genetic and psychological combinations are predictive of shoulder pain phenotypes.J Pain. 2014 Jan;15(1):68-80. doi: 10.1016/j.jpain.2013.09.012. Epub 2013 Oct 5.
396 Importin 5 Regulates Anxiety through MeCP2 and Sphingosine Kinase 1.Cell Rep. 2018 Dec 11;25(11):3169-3179.e7. doi: 10.1016/j.celrep.2018.11.066.
397 Cystic cerebellar dysplasia and biallelic LAMA1 mutations: a lamininopathy associated with tics, obsessive compulsive traits and myopia due to cell adhesion and migration defects.J Med Genet. 2016 May;53(5):318-29. doi: 10.1136/jmedgenet-2015-103416. Epub 2016 Jan 13.
398 The involvement of the vasopressin system in stress-related disorders.CNS Neurol Disord Drug Targets. 2006 Apr;5(2):167-79. doi: 10.2174/187152706776359664.
399 Temperament clusters associate with anxiety disorder comorbidity in depression.J Affect Disord. 2018 Aug 15;236:252-258. doi: 10.1016/j.jad.2018.04.084. Epub 2018 Apr 23.
400 Loss of Maged1 results in obesity, deficits of social interactions, impaired sexual behavior and severe alteration of mature oxytocin production in the hypothalamus.Hum Mol Genet. 2012 Nov 1;21(21):4703-17. doi: 10.1093/hmg/dds310. Epub 2012 Aug 2.
401 Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.Cell Mol Life Sci. 2012 Nov;69(21):3683-700. doi: 10.1007/s00018-012-1047-9. Epub 2012 Jun 22.
402 When Emotional Pain Becomes Physical: Adverse Childhood Experiences, Pain, and the Role of Mood and Anxiety Disorders.J Clin Psychol. 2017 Oct;73(10):1403-1428. doi: 10.1002/jclp.22444. Epub 2017 Mar 22.
403 Mitochondrial Gene Expression Profiles Are Associated with Maternal Psychosocial Stress in Pregnancy and Infant Temperament.PLoS One. 2015 Sep 29;10(9):e0138929. doi: 10.1371/journal.pone.0138929. eCollection 2015.
404 Cornelia de Lange syndrome: a case study.Genet Test Mol Biomarkers. 2009 Feb;13(1):15-8. doi: 10.1089/gtmb.2008.0057.
405 High resolution magnetic resonance imaging for characterization of the neuroligin-3 knock-in mouse model associated with autism spectrum disorder.PLoS One. 2014 Oct 9;9(10):e109872. doi: 10.1371/journal.pone.0109872. eCollection 2014.
406 NPAS2 Regulation of Anxiety-Like Behavior and GABAA Receptors.Front Mol Neurosci. 2017 Nov 3;10:360. doi: 10.3389/fnmol.2017.00360. eCollection 2017.
407 Alterations in anxiety and social behaviour in Npas4 deficient mice following photochemically-induced focal cortical stroke.Behav Brain Res. 2017 Jan 1;316:29-37. doi: 10.1016/j.bbr.2016.08.050. Epub 2016 Aug 26.
408 Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.J Gen Intern Med. 2019 Jun;34(6):862-870. doi: 10.1007/s11606-019-04858-2. Epub 2019 Mar 7.
409 Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception.J Biol Chem. 2001 Oct 5;276(40):36961-9. doi: 10.1074/jbc.M105308200. Epub 2001 Jul 31.
410 Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence.Mol Psychiatry. 2014 Jul;19(7):801-10. doi: 10.1038/mp.2013.104. Epub 2013 Sep 3.
411 Hippocampal expression of a virus-derived protein impairs memory in mice.Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1611-1616. doi: 10.1073/pnas.1711977115. Epub 2018 Jan 29.
412 The pain course: a randomised controlled trial comparing a remote-delivered chronic pain management program when provided in online and workbook formats.Pain. 2017 Jul;158(7):1289-1301. doi: 10.1097/j.pain.0000000000000916.
413 Is therapist evaluation of Social Anxiety/Avoidance traits associated with patient-reported attachment style?.Psychiatry Res. 2017 Nov;257:526-532. doi: 10.1016/j.psychres.2017.08.005. Epub 2017 Aug 10.
414 Mid-childhood outcomes of infant siblings at familial high-risk of autism spectrum disorder.Autism Res. 2017 Mar;10(3):546-557. doi: 10.1002/aur.1733. Epub 2016 Nov 29.
415 Interaction of the neuropeptide S receptor gene AsnIle variant and environment: contribution to affective and anxiety disorders, and suicidal behaviour.Int J Neuropsychopharmacol. 2014 Apr;17(4):541-52. doi: 10.1017/S1461145713001478. Epub 2013 Dec 16.
416 Age-dependent differential regulation of anxiety- and depression-related behaviors by neurabin and spinophilin.PLoS One. 2017 Jul 10;12(7):e0180638. doi: 10.1371/journal.pone.0180638. eCollection 2017.
417 PRND 3'UTR polymorphism may be associated with behavioral disturbances in Alzheimer disease.Prion. 2012 Jan-Mar;6(1):73-80. doi: 10.4161/pri.6.1.18428.
418 Lactobacillus paracasei PS23 reduced early-life stress abnormalities in maternal separation mouse model.Benef Microbes. 2019 Apr 19;10(4):425-436. doi: 10.3920/BM2018.0077. Epub 2019 Mar 18.
419 G7-specific prothymosin alpha deletion causes stress- and age-dependent motor dysfunction and anxiety.Biochem Biophys Res Commun. 2020 Jan 29;522(1):264-269. doi: 10.1016/j.bbrc.2019.11.103. Epub 2019 Nov 20.
420 Brain specific Lamellipodin knockout results in hyperactivity and increased anxiety of mice.Sci Rep. 2017 Jul 14;7(1):5365. doi: 10.1038/s41598-017-05043-3.
421 Hippocampal nuclear factor kappa B accounts for stress-induced anxiety behaviors via enhancing neuronal nitric oxide synthase (nNOS)-carboxy-terminal PDZ ligand of nNOS-Dexras1 coupling.J Neurochem. 2018 Sep;146(5):598-612. doi: 10.1111/jnc.14478. Epub 2018 Aug 2.
422 An EJC factor RBM8a regulates anxiety behaviors.Curr Mol Med. 2013 Jul;13(6):887-99. doi: 10.2174/15665240113139990019.
423 Regulator of calcineurin 1 modulates expression of innate anxiety and anxiogenic responses to selective serotonin reuptake inhibitor treatment.J Neurosci. 2013 Oct 23;33(43):16930-44. doi: 10.1523/JNEUROSCI.3513-12.2013.
424 Subthreshold depressions: clinical and polysomnographic validation of dysthymic, residual and masked forms.J Affect Disord. 1997 Aug;45(1-2):53-63. doi: 10.1016/s0165-0327(97)00059-1.
425 Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy.Am Heart J. 2017 Jul;189:75-84. doi: 10.1016/j.ahj.2017.03.009. Epub 2017 Mar 20.
426 Evaluation of the PAI-A Anxiety and Depression Scales: Evidence of Construct Validity.J Pers Assess. 2018 May-Jun;100(3):313-320. doi: 10.1080/00223891.2017.1347569. Epub 2017 Jul 31.
427 SGCE mutations cause psychiatric disorders: clinical and genetic characterization.Brain. 2013 Jan;136(Pt 1):294-303. doi: 10.1093/brain/aws308.
428 Overexpression of Spexin 1 in the Dorsal Habenula Reduces Anxiety in Zebrafish.Front Neural Circuits. 2019 Aug 14;13:53. doi: 10.3389/fncir.2019.00053. eCollection 2019.
429 Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signaling.Mol Psychiatry. 2019 Sep;24(9):1329-1350. doi: 10.1038/s41380-018-0025-5. Epub 2018 Feb 21.
430 The effect of intracerebroventricular administration of orexin receptor type 2 antagonist on pentylenetetrazol-induced kindled seizures and anxiety in rats.BMC Neurosci. 2018 Aug 13;19(1):49. doi: 10.1186/s12868-018-0445-9.
431 Teneurin proteins possess a carboxy terminal sequence with neuromodulatory activity.Brain Res Mol Brain Res. 2005 Feb 18;133(2):253-65. doi: 10.1016/j.molbrainres.2004.10.019.
432 Single-nucleotide polymorphism in the human TIA1 gene interacts with stressful life events to predict the development of pathological anxiety symptoms in a Swedish population.J Affect Disord. 2020 Jan 1;260:597-603. doi: 10.1016/j.jad.2019.09.018. Epub 2019 Sep 3.
433 Comparison of Neurological and Cognitive Deficits in Children With ADHD and Anxiety Disorders.J Atten Disord. 2018 Mar;22(5):472-485. doi: 10.1177/1087054715578003. Epub 2015 Jun 15.
434 Anxiety Associated Increased CpG Methylation in the Promoter of Asb1: A Translational Approach Evidenced by Epidemiological and Clinical Studies and a Murine Model.Neuropsychopharmacology. 2018 Jan;43(2):342-353. doi: 10.1038/npp.2017.102. Epub 2017 May 25.
435 Psychological factors predict an unfavorable pain trajectory after hysterectomy: a prospective cohort study on chronic postsurgical pain.Pain. 2018 May;159(5):956-967. doi: 10.1097/j.pain.0000000000001170.
436 Perceived Pain Extent is Not Associated With Widespread Pressure Pain Sensitivity, Clinical Features, Related Disability, Anxiety, or Depression in Women With Episodic Migraine.Clin J Pain. 2018 Mar;34(3):217-221. doi: 10.1097/AJP.0000000000000537.
437 Homer2 within the central nucleus of the amygdala modulates withdrawal-induced anxiety in a mouse model of binge-drinking.Neuropharmacology. 2018 Jan;128:448-459. doi: 10.1016/j.neuropharm.2017.11.001. Epub 2017 Nov 3.
438 Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study).Neurogastroenterol Motil. 2018 Jul;30(7):e13319. doi: 10.1111/nmo.13319. Epub 2018 Mar 2.
439 Loss of Lypd6 leads to reduced anxiety-like behaviour and enhanced responses to nicotine.Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:86-94. doi: 10.1016/j.pnpbp.2017.11.025. Epub 2017 Nov 28.
440 Effects of anxiety sensitivity reduction on smoking abstinence: An analysis from a panic prevention program.J Consult Clin Psychol. 2018 May;86(5):474-485. doi: 10.1037/ccp0000288.
441 Deletion of Dtnbp1 in mice impairs threat memory consolidation and is associated with enhanced inhibitory drive in the amygdala.Transl Psychiatry. 2019 Apr 9;9(1):132. doi: 10.1038/s41398-019-0465-y.
442 The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice.J Biol Chem. 2011 Dec 9;286(49):42051-42062. doi: 10.1074/jbc.M111.300541. Epub 2011 Oct 17.
443 Zfp462 deficiency causes anxiety-like behaviors with excessive self-grooming in mice.Genes Brain Behav. 2017 Feb;16(2):296-307. doi: 10.1111/gbb.12339. Epub 2016 Oct 7.
444 [Olygopeptide KND as a putative endogenous prototype of delta sleep inducing peptide (DSIP). Comparative study of biological properties].Bioorg Khim. 2013 May-Jun;39(3):277-84. doi: 10.1134/s1068162013030096.
445 Relationships between coping, anxiety, depression and health-related quality of life in outpatients with substance use disorders: results of the SUBUSQOL study.Psychol Health Med. 2020 Feb;25(2):179-189. doi: 10.1080/13548506.2019.1679847. Epub 2019 Oct 17.
446 Viral-mediated overexpression of the Myelin Transcription Factor 1 (MyT1) in the dentate gyrus attenuates anxiety- and ethanol-related behaviors in rats.Psychopharmacology (Berl). 2017 Jun;234(12):1829-1840. doi: 10.1007/s00213-017-4588-7. Epub 2017 Mar 16.
447 The nuclear receptor corepressor has organizational effects within the developing amygdala on juvenile social play and anxiety-like behavior.Endocrinology. 2010 Mar;151(3):1212-20. doi: 10.1210/en.2009-0594. Epub 2010 Jan 5.
448 Lack of association between SNPs in the NEUROD2 gene and alcohol dependence in a German patient sample.Psychiatry Res. 2011 May 15;187(1-2):220-3. doi: 10.1016/j.psychres.2010.08.031. Epub 2010 Sep 28.
449 Anxiety and somatic symptoms among elderly patients with depression.Asian J Psychiatr. 2019 Mar;41:66-72. doi: 10.1016/j.ajp.2018.07.009. Epub 2018 Jul 18.
450 Polymorphism in Tmem132d regulates expression and anxiety-related behavior through binding of RNA polymerase II complex.Transl Psychiatry. 2018 Jan 10;8(1):1. doi: 10.1038/s41398-017-0025-2.
451 Music therapy and Alzheimer's disease: Cognitive, psychological, and behavioural effects.Neurologia. 2017 Jun;32(5):300-308. doi: 10.1016/j.nrl.2015.12.003. Epub 2016 Feb 17.
452 Further evidence for genetic variation at the serotonin transporter gene SLC6A4 contributing toward anxiety.Psychiatr Genet. 2017 Jun;27(3):96-102. doi: 10.1097/YPG.0000000000000171.
453 Psychological predictors of quality of life and functional outcome in patients undergoing elective surgery for degenerative lumbar spine disease.Eur Spine J. 2020 Feb;29(2):349-359. doi: 10.1007/s00586-019-06106-x. Epub 2019 Aug 14.
454 Assessment of oral health-related quality of life, measured by OHIP-14 and GOHAI, and psychological profiling in burning mouth syndrome: A case-control clinical study.J Oral Rehabil. 2020 Jan;47(1):42-52. doi: 10.1111/joor.12864. Epub 2019 Aug 10.
455 Problematic internet use and psychiatric co-morbidity in a population of Japanese adult psychiatric patients.BMC Psychiatry. 2018 Jan 17;18(1):9. doi: 10.1186/s12888-018-1588-z.
456 Family contributions to sport performance and their utility in predicting appropriate referrals to mental health optimization programmes.Eur J Sport Sci. 2019 Aug;19(7):972-982. doi: 10.1080/17461391.2019.1574906. Epub 2019 Feb 8.
457 Anxiety, Depression, and Pain Symptoms: Associations With the Course of Marijuana Use and Drug Use Consequences Among Urban Primary Care Patients.J Addict Med. 2018 Jan/Feb;12(1):45-52. doi: 10.1097/ADM.0000000000000362.
458 Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics.J Consult Clin Psychol. 2018 Jan;86(1):81-88. doi: 10.1037/ccp0000276.
459 Expression of the PPM1F Gene Is Regulated by Stress and Associated With Anxiety and Depression.Biol Psychiatry. 2018 Feb 1;83(3):284-295. doi: 10.1016/j.biopsych.2017.08.013. Epub 2017 Aug 30.
460 Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.Proc Natl Acad Sci U S A. 2019 May 28;116(22):10943-10951. doi: 10.1073/pnas.1901777116. Epub 2019 May 16.
461 Abrogated Freud-1/Cc2d1a Repression of 5-HT1A Autoreceptors Induces Fluoxetine-Resistant Anxiety/Depression-Like Behavior.J Neurosci. 2017 Dec 6;37(49):11967-11978. doi: 10.1523/JNEUROSCI.1668-17.2017. Epub 2017 Nov 3.
462 High Rates of Psychiatric Comorbidity in Narcolepsy: Findings From the Burden of Narcolepsy Disease (BOND) Study of 9,312 Patients in the United States.J Clin Psychiatry. 2017 Feb;78(2):171-176. doi: 10.4088/JCP.15m10262.
463 Benefit of continuous positive airway pressure on work quality in patients with severe obstructive sleep apnea.Sleep Breath. 2019 Sep;23(3):753-759. doi: 10.1007/s11325-018-01773-4. Epub 2019 Jan 26.
464 Opioid use before and after completion of an online pain management program.J Consult Clin Psychol. 2019 Oct;87(10):904-917. doi: 10.1037/ccp0000407.
465 The role of clock genes in the etiology of Major Depressive Disorder: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.J Affect Disord. 2018 Jul;234:351-357. doi: 10.1016/j.jad.2017.11.015. Epub 2017 Nov 7.
466 Psychosocial and Cardiometabolic Health of Patients With Differing Body Mass Index Completing Cardiac Rehabilitation.Can J Cardiol. 2019 Jun;35(6):712-720. doi: 10.1016/j.cjca.2019.02.024. Epub 2019 Mar 6.
467 Melatonin ameliorates anxiety and depression-like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer's disease.Biofactors. 2017 Jul 8;43(4):593-611. doi: 10.1002/biof.1369. Epub 2017 Jun 13.
468 Poor sleep quality increases symptoms of depression and anxiety in postpartum women.J Behav Med. 2018 Oct;41(5):703-710. doi: 10.1007/s10865-018-9950-7. Epub 2018 Jul 20.
469 Determining Factors for Stress Perception Assessed with the Perceived Stress Scale (PSS-4) in Spanish and Other European Samples.Front Psychol. 2018 Jan 26;9:37. doi: 10.3389/fpsyg.2018.00037. eCollection 2018.
470 Evaluation of depression, anxiety and stress levels in patients with oral lichen planus.J Oral Sci. 2019 Aug 28;61(3):391-397. doi: 10.2334/josnusd.18-0113. Epub 2019 Jun 10.
471 Are there depression and anxiety genetic markers and mutations? A systematic review.J Affect Disord. 2014 Oct;168:387-98. doi: 10.1016/j.jad.2014.07.016. Epub 2014 Jul 22.
472 DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt/-catenin signaling.Mol Psychiatry. 2018 Feb;23(2):467-475. doi: 10.1038/mp.2016.184. Epub 2016 Oct 18.
473 Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder.J Affect Disord. 2013 Dec;151(3):967-72. doi: 10.1016/j.jad.2013.08.017. Epub 2013 Aug 27.
474 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety.Am J Drug Alcohol Abuse. 2019;45(2):161-169. doi: 10.1080/00952990.2018.1545024. Epub 2019 Mar 1.
475 Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care.J Psychoactive Drugs. 2019 Apr-Jun;51(2):102-107. doi: 10.1080/02791072.2019.1581308. Epub 2019 Mar 1.
476 Ablation of hippocampal neurogenesis in mice impairs the response to stress during the dark cycle.Nat Commun. 2015 Sep 29;6:8373. doi: 10.1038/ncomms9373.
477 Preoperative Carbohydrate Loading in Gynecological Patients Undergoing Combined Spinal and Epidural Anesthesia.J Invest Surg. 2020 Aug;33(7):587-595. doi: 10.1080/08941939.2018.1546352. Epub 2019 Jan 15.
478 Somatic effects of AAS abuse: A 30-years follow-up study of male former power sports athletes.J Sci Med Sport. 2017 Sep;20(9):814-818. doi: 10.1016/j.jsams.2017.03.008. Epub 2017 Mar 21.
479 Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses.Neurogastroenterol Motil. 2019 Aug;31(8):e13619. doi: 10.1111/nmo.13619. Epub 2019 May 5.
480 Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).Methods Mol Biol. 2019;1942:173-189. doi: 10.1007/978-1-4939-9080-1_15.
481 Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3 Are Modulators of Anxiety and Glutamatergic Neurotransmission.Front Mol Neurosci. 2018 Apr 12;11:119. doi: 10.3389/fnmol.2018.00119. eCollection 2018.
482 Brain galanin system genes interact with life stresses in depression-related phenotypes.Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):E1666-73. doi: 10.1073/pnas.1403649111. Epub 2014 Mar 24.
483 Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains.Psychopharmacology (Berl). 2012 May;221(2):297-315. doi: 10.1007/s00213-011-2574-z. Epub 2011 Nov 24.
484 Search trends preceding increases in suicide: A cross-correlation study of monthly Google search volume and suicide rate using transfer function models.J Affect Disord. 2020 Feb 1;262:155-164. doi: 10.1016/j.jad.2019.11.014. Epub 2019 Nov 4.
485 Variation in the Williams syndrome GTF2I gene and anxiety proneness interactively affect prefrontal cortical response to aversive stimuli.Transl Psychiatry. 2015 Aug 18;5(8):e622. doi: 10.1038/tp.2015.98.
486 Longitudinal Evaluation of the Cognitive-Behavioral Model of ADHD in a Sample of College Students With ADHD.J Atten Disord. 2018 Feb;22(4):323-333. doi: 10.1177/1087054715616184. Epub 2015 Dec 4.
487 Screening for posttraumatic stress disorder in ARDS survivors: validation of the Impact of Event Scale-6 (IES-6).Crit Care. 2019 Aug 7;23(1):276. doi: 10.1186/s13054-019-2553-z.
488 Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.Inflamm Bowel Dis. 2019 Jan 10;25(2):360-368. doi: 10.1093/ibd/izy235.
489 Facial gender but not emotion distinguishes neural responses of 10- to 13-year-old children with social anxiety disorder from healthy and clinical controls.Biol Psychol. 2018 May;135:36-46. doi: 10.1016/j.biopsycho.2018.02.004. Epub 2018 Feb 13.
490 Associations between LSAMP gene polymorphisms and major depressive disorder and panic disorder.Transl Psychiatry. 2012 Aug 14;2(8):e152. doi: 10.1038/tp.2012.74.
491 An Internet-Based Compassion-Focused Intervention for Increased Self-Criticism: A Randomized Controlled Trial.Behav Ther. 2019 Mar;50(2):430-445. doi: 10.1016/j.beth.2018.08.003. Epub 2018 Aug 17.
492 S-SCAM, a rare copy number variation gene, induces schizophrenia-related endophenotypes in transgenic mouse model.J Neurosci. 2015 Feb 4;35(5):1892-904. doi: 10.1523/JNEUROSCI.3658-14.2015.
493 The -endomannosidase gene (MANEA) is associated with panic disorder and social anxiety disorder.Transl Psychiatry. 2014 Jan 28;4(1):e353. doi: 10.1038/tp.2013.122.
494 An Exploratory Study on the Effects of Forest Therapy on Sleep Quality in Patients with Gastrointestinal Tract Cancers.Int J Environ Res Public Health. 2019 Jul 10;16(14):2449. doi: 10.3390/ijerph16142449.
495 Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities.Mol Psychiatry. 2014 Mar;19(3):368-79. doi: 10.1038/mp.2013.42. Epub 2013 Apr 16.
496 Association of anxiety with subcortical amyloidosis in cognitively normal older adults.Mol Psychiatry. 2020 Oct;25(10):2599-2607. doi: 10.1038/s41380-018-0214-2. Epub 2018 Aug 16.
497 Genome-wide and gene-based association studies of anxiety disorders in European and African American samples.PLoS One. 2014 Nov 12;9(11):e112559. doi: 10.1371/journal.pone.0112559. eCollection 2014.
498 Using Mobile Sensing to Test Clinical Models of Depression, Social Anxiety, State Affect, and Social Isolation Among College Students.J Med Internet Res. 2017 Mar 3;19(3):e62. doi: 10.2196/jmir.6820.
499 Characteristics of new depression diagnoses in patients with and without prior chronic opioid use.J Affect Disord. 2017 Mar 1;210:125-129. doi: 10.1016/j.jad.2016.12.027. Epub 2016 Dec 21.
500 Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity.Am J Med Genet A. 2017 Jan;173(1):213-216. doi: 10.1002/ajmg.a.37977. Epub 2016 Nov 16.
501 Behavioral phenotypes in males with XYY and possible role of increased NLGN4Y expression in autism features.Genes Brain Behav. 2015 Feb;14(2):137-44. doi: 10.1111/gbb.12200. Epub 2015 Feb 1.
502 Neuroplastin 65 modulates anxiety- and depression-like behavior likely through adult hippocampal neurogenesis and central 5-HT activity.FEBS J. 2019 Sep;286(17):3401-3415. doi: 10.1111/febs.14865. Epub 2019 May 13.
503 Serotonin receptor 3A polymorphism c.-42C > T is associated with severe dyspepsia.BMC Med Genet. 2011 Oct 20;12:140. doi: 10.1186/1471-2350-12-140.
504 Examining the relationships between error-related brain activity (the ERN) and anxiety disorders versus externalizing disorders in young children: Focusing on cognitive control, fear, and shyness.Compr Psychiatry. 2018 Nov;87:112-119. doi: 10.1016/j.comppsych.2018.09.009. Epub 2018 Oct 7.
505 Disruption of the homeodomain transcription factor orthopedia homeobox (Otp) is associated with obesity and anxiety.Mol Metab. 2017 Nov;6(11):1419-1428. doi: 10.1016/j.molmet.2017.08.006. Epub 2017 Aug 24.
506 Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice.J Neurosci. 2009 Feb 18;29(7):2259-71. doi: 10.1523/JNEUROSCI.5593-08.2009.
507 Pannexin-1 channel dysfunction in the medial prefrontal cortex mediates depressive-like behaviors induced by chronic social defeat stress and administration of mefloquine in mice.Neuropharmacology. 2018 Jul 15;137:256-267. doi: 10.1016/j.neuropharm.2017.12.004. Epub 2017 Dec 6.
508 Single prolonged stress PTSD model triggers progressive severity of anxiety, altered gene expression in locus coeruleus and hypothalamus and effected sensitivity to NPY.Eur Neuropsychopharmacol. 2019 Apr;29(4):482-492. doi: 10.1016/j.euroneuro.2019.02.010. Epub 2019 Mar 14.
509 Loss of offspring Peg3 reduces neonatal ultrasonic vocalizations and increases maternal anxiety in wild-type mothers.Hum Mol Genet. 2018 Feb 1;27(3):440-450. doi: 10.1093/hmg/ddx412.
510 A Measure of Suffering in relation to Anxiety and Quality of Life in IBS Patients: Preliminary Results.Biomed Res Int. 2017;2017:2387681. doi: 10.1155/2017/2387681. Epub 2017 Jul 4.
511 Modeling Strengthens Molecular Link between Circadian Polymorphisms and Major Mood Disorders.J Biol Rhythms. 2018 Jun;33(3):318-336. doi: 10.1177/0748730418764540. Epub 2018 Apr 3.
512 Interneuronal -GABA(A) receptors regulate binge drinking and are necessary for the behavioral effects of early withdrawal.Neuropsychopharmacology. 2019 Jan;44(2):425-434. doi: 10.1038/s41386-018-0164-z. Epub 2018 Jul 28.
513 How much is too much? Phenotypic consequences of Rai1 overexpression in mice.Eur J Hum Genet. 2008 Aug;16(8):941-54. doi: 10.1038/ejhg.2008.21. Epub 2008 Feb 20.
514 REST/NRSF transcription factor is overexpressed in hippocampus of patients with drug-resistant mesial temporal lobe epilepsy.Epilepsy Behav. 2019 May;94:118-123. doi: 10.1016/j.yebeh.2019.02.012. Epub 2019 Mar 21.
515 Genetic association between RGS1 and internalizing disorders.Psychiatr Genet. 2013 Apr;23(2):56-60. doi: 10.1097/YPG.0b013e32835d7048.
516 Molecular and cellular basis of obsessive-compulsive disorder-like behaviors: emerging view from mouse models.Curr Opin Neurol. 2011 Apr;24(2):114-8. doi: 10.1097/WCO.0b013e32834451fb.
517 The role of phoenixin in behavior and food intake.Peptides. 2019 Apr;114:38-43. doi: 10.1016/j.peptides.2019.04.002. Epub 2019 Apr 3.
518 SRS-22r legacy scores can be accurately translated to PROMIS scores in adult spinal deformity patients.Spine J. 2020 Feb;20(2):234-240. doi: 10.1016/j.spinee.2019.09.006. Epub 2019 Sep 13.
519 Inflammatory markers as predictors of depression and anxiety in adolescents: Statistical model building with component-wise gradient boosting.J Affect Disord. 2018 Jul;234:276-281. doi: 10.1016/j.jad.2018.03.006. Epub 2018 Mar 12.
520 A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders.Transl Psychiatry. 2019 May 23;9(1):150. doi: 10.1038/s41398-019-0481-y.
521 Targeted knockout of a chemokine-like gene increases anxiety and fear responses.Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E1041-E1050. doi: 10.1073/pnas.1707663115. Epub 2018 Jan 16.
522 Hashimoto's thyroiditis induces neuroinflammation and emotional alterations in euthyroid mice.J Neuroinflammation. 2018 Oct 29;15(1):299. doi: 10.1186/s12974-018-1341-z.
523 Widespread pain in axial spondyloarthritis: clinical importance and gender differences.Arthritis Res Ther. 2018 Jul 27;20(1):156. doi: 10.1186/s13075-018-1626-8.
524 Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort.BMJ Open. 2019 Jan 17;9(1):e024719. doi: 10.1136/bmjopen-2018-024719.
525 Prevalence and determinants of anxiety disorders among adolescents in a rural community from northern India.Asian J Psychiatr. 2019 Jun;43:137-142. doi: 10.1016/j.ajp.2019.05.009. Epub 2019 May 3.
526 The impact of silencing feed-forward parvalbumin-expressing inhibitory interneurons in the cortico-thalamocortical network on seizure generation and behaviour.Neurobiol Dis. 2019 Dec;132:104610. doi: 10.1016/j.nbd.2019.104610. Epub 2019 Sep 5.
527 Dendritic spine morphology and memory formation depend on postsynaptic Caskin proteins.Sci Rep. 2019 Nov 14;9(1):16843. doi: 10.1038/s41598-019-53317-9.
528 Prevalence and Correlates of Past-Year Recovery From DSM-5 Alcohol Use Disorder: Results From National Epidemiologic Survey on Alcohol and Related Conditions-III.Alcohol Clin Exp Res. 2019 Nov;43(11):2406-2420. doi: 10.1111/acer.14192. Epub 2019 Oct 3.
529 Long lasting behavioural effects on cuprizone fed mice after neurotoxicant withdrawal.Behav Brain Res. 2019 May 2;363:38-44. doi: 10.1016/j.bbr.2019.01.036. Epub 2019 Jan 28.
530 Altered default mode network connectivity in adolescents with post-traumatic stress disorder.Neuroimage Clin. 2019;22:101731. doi: 10.1016/j.nicl.2019.101731. Epub 2019 Feb 22.
531 The alpha- and beta-noradrenergic receptors blockade in the dorsal raphe nucleus impairs the panic-like response elaborated by medial hypothalamus neurons.Brain Res. 2019 Dec 15;1725:146468. doi: 10.1016/j.brainres.2019.146468. Epub 2019 Sep 18.
532 Systemic administration of a delta opioid receptor agonist, KNT-127, facilitates extinction learning of fear memory in rats.J Pharmacol Sci. 2019 Mar;139(3):174-179. doi: 10.1016/j.jphs.2019.01.002. Epub 2019 Jan 17.
533 Cognitive interference as a possible therapeutic strategy to prevent expression of benzodiazepine withdrawal.Eur J Neurosci. 2019 Dec;50(11):3843-3854. doi: 10.1111/ejn.14515. Epub 2019 Jul 29.
534 Sustained overexpression of neuropeptide S in the amygdala reduces anxiety-like behavior in rats.Behav Brain Res. 2019 Jul 23;367:28-34. doi: 10.1016/j.bbr.2019.03.039. Epub 2019 Mar 23.
535 Hyperactive and anxiolytic-like behaviors result from loss of COUP-TFI/Nr2f1 in the mouse cortex.Genes Brain Behav. 2019 Sep;18(7):e12556. doi: 10.1111/gbb.12556. Epub 2019 Feb 10.
536 Null mutation in P4h-tm leads to decreased fear and anxiety and increased social behavior in mice.Neuropharmacology. 2019 Jul 15;153:63-72. doi: 10.1016/j.neuropharm.2019.04.023. Epub 2019 Apr 25.
537 The emerging role of SHANK genes in neuropsychiatric disorders.Dev Neurobiol. 2014 Feb;74(2):113-22. doi: 10.1002/dneu.22128. Epub 2013 Oct 7.
538 Substance P: A neuropeptide involved in the psychopathology of anxiety disorders.Neuropeptides. 2020 Feb;79:101993. doi: 10.1016/j.npep.2019.101993. Epub 2019 Nov 11.
539 Dcf1 Affects Memory and Anxiety by Regulating NMDA and AMPA Receptors.Neurochem Res. 2019 Nov;44(11):2499-2505. doi: 10.1007/s11064-019-02866-6. Epub 2019 Sep 17.